<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:blogger='http://schemas.google.com/blogger/2008' xmlns:georss='http://www.georss.org/georss' xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-2421819119883582274</id><updated>2026-04-23T15:01:34.507+05:30</updated><category term="Guidelines"/><category term="Regulatory Agencies"/><category term="FDA"/><category term="ICH Guidelines"/><category term="Covid-19"/><category term="Training"/><category term="Quality Assurance"/><category term="Validation/Calibration"/><category term="WHO"/><title type='text'>Pharmaceutical Guidelines/Updates</title><subtitle type='html'>A blog about pharmaceutical Quality Assurance, Quality Control, Production and Regulatory Updates Provided by Regulatory Agencies.</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default?redirect=false'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>22</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-1491473372915184494</id><published>2021-02-14T09:31:00.004+05:30</published><updated>2021-02-14T09:34:19.857+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="FDA"/><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="WHO"/><title type='text'>Data Governance and Data Integrity (DI)</title><content type='html'>&lt;p&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;Introduction:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;Data governance and data
integrity (DI) are important elements in ensuring the reliability of data and
information obtained in the production and control of pharmaceutical products. The
data and information should be complete as well as being attributable, legible,
contemporaneous, original and accurate, commonly referred to as meeting “ALCOA”
principles.&lt;/span&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;/p&gt;&lt;div style=&quot;text-align: center;&quot;&gt;&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2021/02/data-governance-and-data-integrity-di.html&quot;&gt;&lt;img alt=&quot;Data Governance and Data Integrity (DI)&quot; border=&quot;0&quot; data-original-height=&quot;223&quot; data-original-width=&quot;303&quot; height=&quot;294&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiXgSqbDh7tEBX3oC_QKeuzzo21-g8j9E95aNrpX9RD7Zbtu2uEWZi3H1mqwSogzj6QP8jh1y_Z7MnCDW40jCjngHA2apf8bJSds4kUP04Ctgl-ad34OUNrvaA_27ft5-Wh3buoURZibAth/w400-h294/STR1-3.jpg&quot; title=&quot;Data Governance and Data Integrity (DI)&quot; width=&quot;400&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;span style=&quot;font-size: 10.5pt;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;span style=&quot;font-size: 10.5pt;&quot;&gt;In recent years, the
number of observations made regarding the integrity of data, documentation and
record management practices during inspections of good manufacturing practice
(GMP), good clinical practice (GCP) and good laboratory practice (GLP) has been
increasing.&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;Possible causes for this
may include &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: 115%; margin-left: 54pt; mso-add-space: auto; mso-list: l2 level1 lfo1; text-align: justify; text-indent: -36pt;&quot;&gt;&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;(i)&lt;span style=&quot;font: 7pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;too much reliance on human practices; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: 115%; margin-left: 54pt; mso-add-space: auto; mso-list: l2 level1 lfo1; text-align: justify; text-indent: -36pt;&quot;&gt;&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;(ii)&lt;span style=&quot;font: 7pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;the use of computerized systems that are not appropriately
managed and validated; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: 115%; margin-left: 54pt; mso-add-space: auto; mso-list: l2 level1 lfo1; text-align: justify; text-indent: -36pt;&quot;&gt;&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;(iii)&lt;span style=&quot;font: 7pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;failure to adequately review and manage original data and
records.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;What is Data Integrity?&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;data integrity refers to
the completeness, consistency, and accuracy of data. Complete, consistent, and
accurate data should be attributable, legible, contemporaneously recorded,
original or a true copy, and accurate (ALCOA).&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;p&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;Principles of data
integrity and good documentation practices:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: 115%; margin-left: 70.9pt; mso-add-space: auto; mso-list: l1 level1 lfo2; text-align: justify; text-indent: -18pt;&quot;&gt;&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;Ø&lt;span style=&quot;font: 7pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;There should be a written
DI policy&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: 115%; margin-left: 70.9pt; mso-add-space: auto; mso-list: l1 level1 lfo2; text-align: justify; text-indent: -18pt;&quot;&gt;&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;Ø&lt;span style=&quot;font: 7pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;Senior management is
responsible for the establishment and implementation of an effective quality
system and a data governance system. This applies to paper and electronic
generated data.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: 115%; margin-left: 70.9pt; mso-add-space: auto; mso-list: l1 level1 lfo2; text-align: justify; text-indent: -18pt;&quot;&gt;&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;Ø&lt;span style=&quot;font: 7pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;Data should be
Attributable, Legible, Contemporaneous, Original, and Accurate (ALCOA) and be
Complete, Consistent, Enduring, and Available (+). This is generally referred
to as ALCOA+.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: 115%; margin-left: 70.9pt; mso-add-space: auto; mso-list: l1 level1 lfo2; text-align: justify; text-indent: -18pt;&quot;&gt;&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;Ø&lt;span style=&quot;font: 7pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;The quality system,
including documentation such as procedures and formats for recording data,
should be appropriately designed and implemented to provide assurance that
records and data meet the principles contained in this guideline.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: 115%; margin-left: 70.9pt; mso-add-space: auto; mso-list: l1 level1 lfo2; text-align: justify; text-indent: -18pt;&quot;&gt;&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;Ø&lt;span style=&quot;font: 7pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;Data governance should
address data ownership and accountability throughout the life cycle and
consider the design, operation and monitoring of processes/systems to comply
with the principles of DI, including control over intentional and unintentional
changes to data.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;Data governance systems
should include:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: 115%; margin-left: 70.9pt; mso-add-space: auto; mso-list: l0 level1 lfo3; text-align: justify; text-indent: -18pt;&quot;&gt;&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;ü&lt;span style=&quot;font: 7pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;training in the importance
of DI principles;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: 115%; margin-left: 70.9pt; mso-add-space: auto; mso-list: l0 level1 lfo3; text-align: justify; text-indent: -18pt;&quot;&gt;&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;ü&lt;span style=&quot;font: 7pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;the creation of an
appropriate working environment;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: 115%; margin-left: 70.9pt; mso-add-space: auto; mso-list: l0 level1 lfo3; text-align: justify; text-indent: -18pt;&quot;&gt;&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;ü&lt;span style=&quot;font: 7pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;active encouragement of
the reporting of errors, omissions and undesirable results.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;References: &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;a href=&quot;https://www.who.int/medicines/areas/quality_safety/quality_assurance/QAS19_819_data_integrity.pdf&quot;&gt;https://www.who.int/medicines/areas/quality_safety/quality_assurance/QAS19_819_data_integrity.pdf&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;a href=&quot;https://www.fda.gov/files/drugs/published/Data-Integrity-and-Compliance-With-Current-Good-Manufacturing-Practice-Guidance-for-Industry.pdf&quot;&gt;https://www.fda.gov/files/drugs/published/Data-Integrity-and-Compliance-With-Current-Good-Manufacturing-Practice-Guidance-for-Industry.pdf&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;&lt;br /&gt;&lt;p&gt;&lt;/p&gt;</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/1491473372915184494/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2021/02/data-governance-and-data-integrity-di.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/1491473372915184494'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/1491473372915184494'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2021/02/data-governance-and-data-integrity-di.html' title='Data Governance and Data Integrity (DI)'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiXgSqbDh7tEBX3oC_QKeuzzo21-g8j9E95aNrpX9RD7Zbtu2uEWZi3H1mqwSogzj6QP8jh1y_Z7MnCDW40jCjngHA2apf8bJSds4kUP04Ctgl-ad34OUNrvaA_27ft5-Wh3buoURZibAth/s72-w400-h294-c/STR1-3.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-2980877321228907585</id><published>2020-12-27T14:02:00.007+05:30</published><updated>2020-12-27T14:12:11.219+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Quality Assurance"/><category scheme="http://www.blogger.com/atom/ns#" term="Training"/><title type='text'>Line Clearance in Pharmaceuticals</title><content type='html'>&lt;p&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: normal; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&amp;nbsp;&lt;b&gt;&lt;span style=&quot;background: white; color: black; mso-color-alt: windowtext;&quot;&gt;Line Clearance&lt;/span&gt;&lt;/b&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0cm; margin-right: 0cm; margin-top: 12.0pt; margin: 12pt 0cm 13.2pt; text-align: justify;&quot;&gt;&lt;b&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;What is Line Clearance :&lt;/span&gt;&lt;/b&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0cm; margin-right: 0cm; margin-top: 12.0pt; margin: 12pt 0cm 13.2pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Line clearance is a process that provides a high
degree of confidence or assurance that the said line or area is free from any
unwanted residue or leftover of previous processing before proceeding with the
next process. Quality assurance has to provide Line clearance before the start
of any activity whether it is batch to batch change over and Product to product
change over.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0cm; margin-right: 0cm; margin-top: 12.0pt; margin: 12pt 0cm 13.2pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: justify;&quot;&gt;&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2020/12/line-clearance-in-pharmaceuticals.html&quot; style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;&lt;img alt=&quot;Line Clearance in Pharmaceuticals&quot; data-original-height=&quot;293&quot; data-original-width=&quot;320&quot; height=&quot;293&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjyOT23uUPkFmRKF87m90JqwmWmeLBZ4ScQe8gK9K9-RxmnG0OL8pz9f-bmK5jV8NAVZSFiNWZvCo06M0I_48bpRrlRwAH6UIb6UA6qPRisIPJk9XZ3wWe6TQ2f4pCGNKBoGbLxrLygqaRx/w320-h293/image.png&quot; title=&quot;Line Clearance in Pharmaceuticals&quot; width=&quot;320&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;p&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0cm; text-align: center;&quot;&gt;&lt;br /&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0cm;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;
&lt;!--[endif]--&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0cm; margin-right: 0cm; margin-top: 12.0pt; margin: 12pt 0cm 13.2pt; text-align: justify;&quot;&gt;&lt;b&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Criteria of Batch to batch change over :&lt;/span&gt;&lt;/b&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0cm; margin-right: 0cm; margin-top: 12.0pt; margin: 12pt 0cm 13.2pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Change over from one batch to another batch of the
same product and same Strength or increasing in strength provided the
excipients are the same.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0cm; margin-right: 0cm; margin-top: 12.0pt; margin: 12pt 0cm 13.2pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Cleaning between batches of the same product but in
ascending or increasing strength.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0cm; margin-right: 0cm; margin-top: 12.0pt; margin: 12pt 0cm 13.2pt; text-align: justify;&quot;&gt;&lt;b&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Criteria of Product to Product change over :&lt;/span&gt;&lt;/b&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;ol start=&quot;1&quot; type=&quot;1&quot;&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l0 level1 lfo1; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Change over from one
     product to another product.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l0 level1 lfo1; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Change over from one
     product to the same product with descending or decreasing strength.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l0 level1 lfo1; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Change over between
     batches/products with different colors Flavour / Excipients.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l0 level1 lfo1; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Change over after post
     maintenance or when the next product is not known (as
     applicable).&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l0 level1 lfo1; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Continuously running
     one batch for a longer period of time.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l0 level1 lfo1; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Area or Equipment is
     kept ideal for more period of time.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
&lt;/ol&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0cm; margin-right: 0cm; margin-top: 12.0pt; margin: 12pt 0cm 13.2pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Line clearance should be carried out at change over
by Manufacturing, Packaging, Raw Material Store, Packing Material Store, etc
independently for the stages where final dosage form &amp;amp; intermediates are formed,
handled and processed.&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;p&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0cm; margin-right: 0cm; margin-top: 12.0pt; margin: 12pt 0cm 13.2pt; text-align: justify;&quot;&gt;&lt;b&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Line clearance for all area should be given as per
the following points (but not limited to) :&lt;/span&gt;&lt;/b&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;ol start=&quot;1&quot; type=&quot;1&quot;&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;On request from the
     concerned area for line clearance, QA will Check all the points/line &amp;amp;
     shall ensure the type of cleaning (Product to Product or Batch to Batch).
     If the machine/Area having Product to Product cleaning, then ensure the
     machine is in dismantling condition and check for the absence of previous
     product/material in each dismantled parts of the machine.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;After complete verification
     of equipment at the dismantled condition from IPQA checklist as well as
     respective documents like batch records to be signed, then the production
     person shall go for assembling of equipment as per the plan.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Once the equipment
     line clearance is done, the equipment can be used up to its cleaning
     validity only, if it crosses the validity date, then re-line clearance of
     equipment shall be done&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Check and ensure that
     the previous product/ batch materials and status labels are removed from
     the area.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Ensure that dustbins
     in the area are emptied out and do not carry debris of previous
     product/batch.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Check the ceiling,
     floor, walls, windows and door frames and electrical panels in the area
     are clean and free from visible traces of previous product/ batch. (Where
     ever applicable).&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Ensure cleanliness of
     Drain point provided in the area&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Ensure cleanliness of
     pendants, dust extraction hose are cleaned&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Ensure cleanliness of
     Weighing balance platform and Display of balance&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Ensure that the
     cleaning record for the area is updated.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Ensure calibration
     status of all pressure gauges, balances and timers are updated&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Check that the
     documents pertaining to the previous product are removed from the area.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Check that the
     equipment log sheets of all machines in the area are complete as on date
     with cleaning details.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Ensure that
     environment conditions (Temperature &amp;amp; RH) record is updated.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Ensure that the Batch
     Manufacturing Record is complete in all respects up to the stage.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Line clearance for all
     equipment should be given as per checkpoints mentioned in checklists and
     for specific areas / Parts of the machine shall be verified accordingly
     the photographs available in the checklist as well as in respective
     Operation and cleaning SOP’s of manufacturing equipment.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Ensure that, the
     rejects of the previous product are destroyed.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Ensure that the area
     and equipment are appropriately labeled for status&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Ensure Batch
     manufacturing record &amp;amp; Batch Packing record are completed up to the
     executed activity and verified.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Check that the
     machines have been cleaned as per respective SOP of the respective
     department for the removal of previous batch/ product.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;The checking during
     line clearance should include all machine places where the product/
     packaging material may get trapped. Use Additional flashlight or
     compressed air is required to ensure the adequacy of cleanliness at
     critical parts/areas.&amp;nbsp;&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&amp;nbsp;All excess /
     rejected packing materials of the previous product shall be removed from
     the line.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&amp;nbsp; All used hand
     gloves, dusters of the previous product shall be removed from the line&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;All stereos of the
     previous product shall be removed/ destroyed by cutting into pieces (as
     applicable).&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;During line clearance
     of primary packing line and secondary packing line Quality Assurance
     personnel shall checks the complete deletion of Pharmacode / Barcode of
     the previous product on PLC/HMI of Machine.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Check the conveyor
     belt and area below the belt for the absence of the previous product.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Tools box checked for
     absence of previous product and Sorting tray checked for absence of the
     previous product.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Verify and ensure the
     correctness of the next product/ batch for label, Integrity, storage &amp;amp;
     other appropriate parameters.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Individual line
     clearance checklist shall be done and checked by production for respective
     equipment which shall be verified by Quality Assurance.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Production and Quality
     Assurance shall check &amp;amp; verify the specimen of Aluminium foil, PVC,
     Carton, label etc before the start of packing activity.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;In case of dispensing
     of Raw &amp;amp; Packing material Quality assurance shall verify the release
     of the same from Quality Control.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Potency Calculation of
     Raw material shall be checked by production &amp;amp; verify by Quality
     Assurance.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
 &lt;li class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-list: l1 level1 lfo2; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list 36.0pt; text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;color: black; font-size: 10.5pt; mso-ansi-language: EN-IN; mso-color-alt: windowtext; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;Individual line
     clearance checklist shall be done and checked by production for respective
     equipment which shall be verified by Quality Assurance.&lt;/span&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; style=&quot;font-size: 10.5pt; mso-ansi-language: EN-IN; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;; mso-fareast-language: EN-IN;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;
&lt;/ol&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;p&gt;&lt;/p&gt;</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/2980877321228907585/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/12/line-clearance-in-pharmaceuticals.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/2980877321228907585'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/2980877321228907585'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/12/line-clearance-in-pharmaceuticals.html' title='Line Clearance in Pharmaceuticals'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjyOT23uUPkFmRKF87m90JqwmWmeLBZ4ScQe8gK9K9-RxmnG0OL8pz9f-bmK5jV8NAVZSFiNWZvCo06M0I_48bpRrlRwAH6UIb6UA6qPRisIPJk9XZ3wWe6TQ2f4pCGNKBoGbLxrLygqaRx/s72-w320-h293-c/image.png" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-9134710913296470995</id><published>2020-11-04T08:19:00.002+05:30</published><updated>2020-11-04T08:31:32.246+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="FDA"/><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><title type='text'>Information Requests and Discipline Review Letters of US FDA</title><content type='html'>&lt;p&gt;&lt;/p&gt;&lt;p class=&quot;MsoListParagraph&quot; style=&quot;line-height: 115%; margin-bottom: 0cm; mso-add-space: auto; mso-list: l4 level1 lfo1; text-indent: -18pt;&quot;&gt;&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Symbol; font-size: 10.5pt; line-height: 115%; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;·&lt;span style=&quot;font: 7pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;The Generic Drug User Fee
Amendments of 2017 (GDUFA II) was signed into law on August 18, 2017 in order
to facilitate timely access to high quality, affordable generic medicines. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Symbol; font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;span face=&quot;Arial, sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;As part of GDUFA II, FDA
agreed to two program enhancements centered on improving communications during
a review-cycle:&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm; margin-left: 42.55pt; margin-right: 0cm; margin-top: 0cm; margin: 0cm 0cm 0cm 42.55pt;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;- Discipline Review Letters;
and &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm; margin-left: 42.55pt; margin-right: 0cm; margin-top: 0cm; margin: 0cm 0cm 0cm 42.55pt;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;- Information Requests. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Symbol; font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;span face=&quot;Arial, sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;The recently published draft
guidance entitled Information Requests and Discipline Review Letters Under
GDUFA, explains how the Agency intends to deploy these two program enhancements
during the review of an original abbreviated new drug application (ANDA).&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm; text-align: center;&quot;&gt;&lt;b&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;Discipline Review Letter (DRL)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;Ø&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span face=&quot;Arial, sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;Generally,
a DRL will be issued from each discipline as it finishes its initial review of
its portion of a received ANDA.&lt;/span&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;Ø&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span face=&quot;Arial, sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;It
will not represent a complete review of the entire submission and does not
necessarily reflect input from all supervisory levels.&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;p&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;Ø&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span face=&quot;Arial, sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;It
allows applicants to know, as soon as possible, early thoughts on possible
deficiencies within specific sections of an application.&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm; text-align: center;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;b style=&quot;text-align: center;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;Information Request (IR)&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;Ø&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span face=&quot;Arial, sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;A
DRL is intended to convey early thoughts on possible deficiencies found during
a discipline review whereas an IR will request further information or
clarification that is needed or would be helpful to proceed with the discipline
review.&lt;/span&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;Ø&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span face=&quot;Arial, sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;As
with DRLs, an IR will not represent a complete review of the entire submission
and will not necessarily reflect input from all supervisory levels.&lt;/span&gt;&lt;/p&gt;

&lt;p align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm; text-align: center;&quot;&gt;&lt;b&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;IR/DRL Timing&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;Ø&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span face=&quot;Arial, sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;Generally,
no later than about the mid-point of the GDUFA goal date: - Discipline reviews
will be complete; and - IRs and/or DRLs will have been issued.&lt;/span&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;Ø&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span face=&quot;Arial, sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;While
DRLs may only be issued after the completion of a discipline review, IRs may be
issued at any time.&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm; text-align: center;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;b style=&quot;text-align: center;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;IR/DRL Responses&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;Ø&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span face=&quot;Arial, sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;DRLs
and IRs may contain a requested response date; an applicant may request a short
extension if they are unable to respond by a requested response date.&lt;/span&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;Ø&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span face=&quot;Arial, sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;Responses
to an IR or a DRL generally will not affect the review clock.&lt;/span&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: Wingdings; font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;Ø&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span face=&quot;Arial, sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%; text-indent: -18pt;&quot;&gt;FDA
will strive to review a response during the review cycle in which it is
received if such review can be completed during such a review cycle.&lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0cm;&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;Reference:&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt;&lt;span face=&quot;&amp;quot;Arial&amp;quot;,sans-serif&quot; lang=&quot;EN-US&quot; style=&quot;font-size: 10.5pt; line-height: 115%;&quot;&gt;
&lt;a href=&quot;https://www.fda.gov/media/109961/download&quot;&gt;https://www.fda.gov/media/109961/download&lt;/a&gt;&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;&lt;br /&gt;&lt;p&gt;&lt;/p&gt;</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/9134710913296470995/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/11/information-requests-and-discipline.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/9134710913296470995'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/9134710913296470995'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/11/information-requests-and-discipline.html' title='Information Requests and Discipline Review Letters of US FDA'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-4057699044841933263</id><published>2020-11-03T21:48:00.002+05:30</published><updated>2020-11-04T08:31:06.134+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Covid-19"/><category scheme="http://www.blogger.com/atom/ns#" term="FDA"/><title type='text'>FDA approves first treatment for COVID-19</title><content type='html'>&lt;div class=&quot;separator&quot;&gt;&lt;p style=&quot;background-color: white; box-sizing: border-box; clear: left; color: #444444; float: left; font-family: &amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif; font-size: 14px; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img align=&quot;right&quot; alt=&quot;FDA&quot; class=&quot;caption&quot; src=&quot;https://www.worldpharmanews.com/images/logo/fda.png&quot; style=&quot;width: 240px;&quot; title=&quot;FDA&quot; /&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;span face=&quot;&amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif&quot; style=&quot;background-color: white; color: #444444; font-size: 14px;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span face=&quot;&amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif&quot; style=&quot;background-color: white; color: #444444; font-size: 14px;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span face=&quot;&amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif&quot; style=&quot;background-color: white; color: #444444; font-size: 14px;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span face=&quot;&amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif&quot; style=&quot;background-color: white; color: #444444; font-size: 14px;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span face=&quot;&amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif&quot; style=&quot;background-color: white; color: #444444; font-size: 14px;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;span face=&quot;&amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif&quot; style=&quot;background-color: white; color: #444444; font-size: 14px;&quot;&gt;The U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization. Veklury should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care. Veklury is the first treatment for COVID-19 to receive FDA approval.&lt;/span&gt;&lt;/p&gt;&lt;p style=&quot;background-color: white; box-sizing: border-box; color: #444444; font-family: &amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif; font-size: 14px; text-align: justify;&quot;&gt;This approval does not include the entire population that had been authorized to use Veklury under an Emergency Use Authorization (EUA) originally issued on May 1, 2020. In order to ensure continued access to the pediatric population previously covered under the EUA, the FDA revised the EUA for Veklury to authorize the drug’s use for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients less than 12 years of age weighing at least 3.5 kg. Clinical trials assessing the safety and efficacy of Veklury in this pediatric patient population are ongoing.&lt;span&gt;&lt;/span&gt;&lt;/p&gt;&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;p&gt;&lt;/p&gt;&lt;p style=&quot;background-color: white; box-sizing: border-box; color: #444444; font-family: &amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif; font-size: 14px; text-align: justify;&quot;&gt;&quot;The FDA is committed to expediting the development and availability of COVID-19 treatments during this unprecedented public health emergency,&quot; said FDA Commissioner Stephen M. Hahn, M.D. &quot;Today&#39;s approval is supported by data from multiple clinical trials that the agency has rigorously assessed and represents an important scientific milestone in the COVID-19 pandemic. As part of the FDA&#39;s Coronavirus Treatment Acceleration Program, the agency will to continue to help move new medical products to patients as soon as possible, while at the same time determining whether they are effective and if their benefits outweigh their risks.&quot;&lt;/p&gt;&lt;p style=&quot;background-color: white; box-sizing: border-box; color: #444444; font-family: &amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif; font-size: 14px; text-align: justify;&quot;&gt;Under the Federal Food, Drug, and Cosmetic Act, approval of a new drug product requires substantial evidence of effectiveness and a demonstration of safety for the drug&#39;s intended use(s). In considering approval of a drug, the FDA conducts a benefit-risk assessment based on rigorous scientific standards to ensure that the product’s benefits outweigh its risks for the intended population. This is different from the standard used in the issuance of an EUA.&lt;/p&gt;&lt;p style=&quot;background-color: white; box-sizing: border-box; color: #444444; font-family: &amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif; font-size: 14px; text-align: justify;&quot;&gt;The approval of Veklury was supported by the agency’s analysis of data from three randomized, controlled clinical trials that included patients hospitalized with mild-to-severe COVID-19.&lt;/p&gt;&lt;p style=&quot;background-color: white; box-sizing: border-box; color: #444444; font-family: &amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif; font-size: 14px; text-align: justify;&quot;&gt;One randomized, double-blind, placebo-controlled clinical trial (ACTT-1), conducted by the National Institute of Allergy and Infectious Diseases, evaluated how long it took for subjects to recover from COVID-19 within 29 days of being treated. The trial looked at 1,062 hospitalized subjects with mild, moderate and severe COVID-19 who received Veklury (n=541) or placebo (n=521), plus standard of care. Recovery was defined as either being discharged from the hospital or being hospitalized but not requiring supplemental oxygen and no longer requiring ongoing medical care. The median time to recovery from COVID-19 was 10 days for the Veklury group compared to 15 days for the placebo group, a statistically significant difference. Overall, the odds of clinical improvement at Day 15 were also statistically significantly higher in the Veklury group when compared to the placebo group.&lt;/p&gt;&lt;p style=&quot;background-color: white; box-sizing: border-box; color: #444444; font-family: &amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif; font-size: 14px; text-align: justify;&quot;&gt;A second randomized, open-label multi-center clinical trial of hospitalized adult subjects with moderate COVID-19 compared treatment with Veklury for five days (n=191) and treatment with Veklury for 10 days (n=193) with standard of care (n=200). Researchers evaluated the clinical status of subjects on Day 11. Overall, the odds of a subject’s COVID-19 symptoms improving were statistically significantly higher in the five-day Veklury group at Day 11 when compared to those receiving only standard of care. The odds of improvement with the 10-day treatment group when compared to those receiving only standard of care were numerically favorable, but not statistically significantly different.&lt;/p&gt;&lt;p style=&quot;background-color: white; box-sizing: border-box; color: #444444; font-family: &amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif; font-size: 14px; text-align: justify;&quot;&gt;A third separate, randomized, open-label multi-center clinical trial of hospitalized adult subjects with severe COVID-19 compared treatment with Veklury for five days (n= 200) and treatment with Veklury for 10 days (n= 197). Researchers evaluated the clinical status of subjects on Day 14. Overall, the odds of a subject’s COVID-19 symptoms improving were similar for those in the five-day Veklury group as those in the 10-day Veklury group, and there were no statistically significant differences in recovery rates or mortality rates between the two groups.&lt;/p&gt;&lt;p style=&quot;background-color: white; box-sizing: border-box; color: #444444; font-family: &amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif; font-size: 14px; text-align: justify;&quot;&gt;Important information about using Veklury to treat COVID-19 for its approved use is available in the prescribing information which includes dosing instructions, potential side effects and drug interactions. Possible side effects include: increased levels of liver enzymes, which may be a sign of liver injury; and allergic reactions, which may include changes in blood pressure and heart rate, low blood oxygen level, fever, shortness of breath, wheezing, swelling (e.g., lips, around eyes, under the skin), rash, nausea, sweating or shivering. Similar safety information about using Veklury to treat COVID-19 in certain hospitalized pediatric patients under the EUA is available in the fact sheets for health care providers and patients/caregivers.&lt;/p&gt;&lt;p style=&quot;background-color: white; box-sizing: border-box; color: #444444; font-family: &amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif; font-size: 14px; text-align: justify;&quot;&gt;The FDA granted this application Fast Track and Priority Review designations. The Agency also granted this application a Material Threat Medical Countermeasure Priority Review Voucher, which provides additional incentives for certain medical products intended to treat or prevent harm from specific chemical, biological, radiological and nuclear threats.&lt;/p&gt;&lt;p style=&quot;background-color: white; box-sizing: border-box; color: #444444; font-family: &amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif; font-size: 14px;&quot;&gt;&lt;br /&gt;&lt;/p&gt;&lt;p style=&quot;background-color: white; box-sizing: border-box; color: #444444; font-family: &amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif; font-size: 14px;&quot;&gt;Reference:&amp;nbsp;&lt;a href=&quot;https://www.worldpharmanews.com/fda/5439-fda-approves-first-treatment-for-covid-19&quot;&gt;https://www.worldpharmanews.com/fda/5439-fda-approves-first-treatment-for-covid-19&lt;/a&gt;&lt;/p&gt;</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/4057699044841933263/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/11/fda-approves-first-treatment-for-covid.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/4057699044841933263'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/4057699044841933263'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/11/fda-approves-first-treatment-for-covid.html' title='FDA approves first treatment for COVID-19'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-3235741210727991857</id><published>2020-07-19T09:42:00.000+05:30</published><updated>2020-07-19T09:43:02.621+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Training"/><title type='text'>Different Types of Training in Pharmaceutical Industries</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Training
plays an important role in any industry and it gives a clear understanding
about the roles and responsibilities of a person working in an organization.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: 0.0001pt; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2020/07/different-types-of-training-in-Pharmaceutical-industries.html&quot;&gt;&lt;img alt=&quot;Different Types of Training in Pharmaceutical Industries&quot; height=&quot;262&quot; src=&quot;https://www.speakactchange.org/wp-content/uploads/2017/11/training-concept-image.jpg&quot; title=&quot;Different Types of Training in Pharmaceutical Industries&quot; width=&quot;400&quot; /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;There
are different types of Training which are as follows:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;(1)&amp;nbsp; Induction Training &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;(2)&amp;nbsp; On Job Training &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;(3)&amp;nbsp; Self Reading Training&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;(4)&amp;nbsp; Class Room Training&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;(5)&amp;nbsp; External Training &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;(6)&amp;nbsp; Incidental Training &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;(7)&amp;nbsp; Refresher Training&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Induction
Training:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Training
given to the new joinee (Employee) at the time of joining the organization for
awareness of organization and organization personnel is termed as Induction
Training.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Whenever
a new employee is joining the organization, on completion of joining procedure,
Personnel – HRA shall give him / her first-hand information regarding the
company’s profile, group activities, service benefits, service rules,
administrative rules, disciplinary rules and personnel hygiene.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;&amp;nbsp;Human Resource department shall also provide
“Induction Manual” for awareness of the organization.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;On
completion of the reading of “Induction Manual”, Personnel – HRA shall take him /
her for plant round to familiar with the plant as well as plant personnel.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;On
Job Training:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Training
given to an employee at the workplace is termed as On Job Training.&lt;/span&gt;&lt;/div&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;On
completion of Induction Training and Departmental Training, department head or
section head or his / her designee shall give “On Job Training” to new employee
at workplace to understand the practical procedure regarding his / her work
profile.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;In
case an employee does not qualify in his / her performance, training need is
assessed by the superior and “On Job Training” shall be given to the employee
again.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Self-Reading
Training:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;The
effects of reading strategy instruction, called Self Reading Training and also self-reading
training includes explaining the meaning of information to self while reading.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Only
qualified trainers shall be read SOPs and cGMP modules and understand the
information/instruction given in that.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Class
Room Training:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Training
given to an employee in classroom or other than work place is termed as Class
Room Training.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;For
the training program, employees will gather at the designated location&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Faculty
shall give training in English and/or Hindi language to all employees and
along with training, wherever required training material shall be given to all
employees.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;External
Training: &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Training
given to employee outside the plant location / by the person other than the
Organization Group is termed as External Training.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Human
Resource &amp;amp; Administration department with the consultation of all department
heads shall prepare an employee list for the external training program&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Incidental
Training: &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Training
given to the employee with respect to the incident to aware the severity/harm of
particular incident.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;In
case some incident happens in the plant, such type of training shall be
conducted for the concerned personnel and Incidental Training Program shall be
announced on an emergency basis.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Refresher
Training: &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Training
given to an employee at a defined frequency to freshen-up the knowledge is
termed as Refresher Training.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;The
Purpose of the refresher training is to ensure that skills among staff remain sharp
and that previous learning is retained and kept current.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Apart from the training
schedule/calendar, cGMP and other refresher SOP training shall be also
conducted throughout the year periodically for the completion of training for
remaining persons.&lt;/span&gt;&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/3235741210727991857/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/07/different-types-of-training-in-Pharmaceutical-industries.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/3235741210727991857'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/3235741210727991857'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/07/different-types-of-training-in-Pharmaceutical-industries.html' title='Different Types of Training in Pharmaceutical Industries'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-5621656419376214062</id><published>2020-06-23T16:19:00.001+05:30</published><updated>2020-06-23T16:19:48.388+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="Regulatory Agencies"/><title type='text'>Comparison of EU and US variation requirements</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;br /&gt;
&lt;div class=&quot;Default&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;Default&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;b&gt;&lt;span style=&quot;mso-spacerun: yes;&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;span class=&quot;A2&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;Arial&amp;quot;,sans-serif;&quot;&gt;Key
points in regulatory management of variations &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;Default&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;b&gt;&lt;span class=&quot;A2&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;Arial&amp;quot;,sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;Pa3&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;• Lifecycle management of pharmaceutical products varies between
the EU and US in terms of different submission requirements and assessment
timelines. However, similarities do exist in regional approaches to a general categorization
of post-approval changes (variations) and in many cases also the principles of
implementation. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;Pa3&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;• Post-approval variations in the EU and US can be administrative
in nature, simple changes requiring minor review, or major changes that are
often complex. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;Default&quot; style=&quot;line-height: 115%;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;Pa3&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;• Administrative: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;EU regulators go
as far as to define “administrative” as a category in their classification
guideline, whereas in other regions they fall into the lowest variation
category and have significant crossover with minor variations, e.g. new
addresses. Many agencies accept that these changes can be implemented without
the need for approval. Prior approval of administrative changes is
time-consuming for agencies and costly for industry. Additionally, in certain
cases such as a marketing authorization holder (MAH) moving address, the change
would actually need to take place prior to submission. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;Default&quot; style=&quot;line-height: 115%;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;Pa3&quot; style=&quot;line-height: 115%; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;• Minor: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Minor variations are generally
considered to have either no impact on the quality of the product or have a
very low chance of impact; and hence lower risk. Consequently, the level of
agency review, and hence the time required is reduced. As regulatory frameworks
have developed, agencies have introduced means to allow the most minor of
variations to be implemented before review. For example, in the EU, when a Type
IA variation is submitted the MAH must state which of a pre-defined list of
conditions applies to its change, thereby reducing the amount of review
required. With minor variations, many agencies have documentation requirements
that are well-established and must be met before variations are submitted. This
ensures that MAHs know what is expected before a submission and can prepare
sufficient supporting data. This leads to faster review times as assessors have
less need to request further data from applicants. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;Default&quot; style=&quot;line-height: 115%;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;• Major: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Where notable alterations to product registration are required,
these are expected to have an impact on a product’s quality and efficacy and as
such are tightly controlled, requiring in-depth assessment and review. The MAH
must demonstrate that the product will retain the same level of quality and
efficacy. Comparative data is a significant requirement for such changes and
must reliably show the proposed changes do not impair product quality.
Assessment times for such variations are often much longer, as agencies
carefully review submissions and frequently make requests for additional data
and answers to questions and concerns.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 107%; mso-ansi-language: EN-US; mso-bidi-language: GU; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-fareast-theme-font: minor-latin;&quot;&gt;&lt;br clear=&quot;all&quot; style=&quot;mso-special-character: line-break; page-break-before: always;&quot; /&gt;
&lt;/span&gt;

&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;table border=&quot;1&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;MsoNormalTable&quot; style=&quot;border-collapse: collapse; border: none; margin-left: -5.4pt; mso-border-alt: solid windowtext .5pt; mso-border-insideh: .5pt solid windowtext; mso-border-insidev: .5pt solid windowtext; mso-padding-alt: 0in 5.4pt 0in 5.4pt; mso-table-layout-alt: fixed; width: 700px;&quot;&gt;
 &lt;tbody&gt;
&lt;tr style=&quot;height: 5.55pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;&quot;&gt;
  &lt;td colspan=&quot;7&quot; style=&quot;background: #FFF2CC; border: solid windowtext 1.0pt; height: 5.55pt; mso-background-themecolor: accent4; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 524.8pt;&quot; width=&quot;700&quot;&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%; mso-ansi-language: EN-US; mso-bidi-language: GU; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-fareast-theme-font: minor-latin;&quot;&gt;&lt;br clear=&quot;all&quot; style=&quot;page-break-before: always;&quot; /&gt;
  &lt;/span&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Table 1: Summary of variations and anticipated implementation
  dates in Europe and US.&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 5.4pt; mso-yfti-irow: 1;&quot;&gt;
  &lt;td colspan=&quot;4&quot; style=&quot;background: #FFF2CC; border-top: none; border: solid windowtext 1.0pt; height: 5.4pt; mso-background-themecolor: accent4; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 279.65pt;&quot; width=&quot;373&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Europe&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td colspan=&quot;3&quot; style=&quot;background: #FFF2CC; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 5.4pt; mso-background-themecolor: accent4; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 245.15pt;&quot; width=&quot;327&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;US&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 16.2pt; mso-yfti-irow: 2;&quot;&gt;
  &lt;td style=&quot;background: #FFF2CC; border-top: none; border: solid windowtext 1.0pt; height: 16.2pt; mso-background-themecolor: accent4; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 54.65pt;&quot; width=&quot;73&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Variation&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: .75in;&quot; width=&quot;72&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Type&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 117.0pt;&quot; width=&quot;156&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Anticipated implementation time&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: .75in;&quot; width=&quot;72&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Guideline approval timeline&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 49.5pt;&quot; width=&quot;66&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Type&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 139.5pt;&quot; width=&quot;186&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Anticipated implementation time&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 56.15pt;&quot; width=&quot;75&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Guideline approval timeline&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 16.2pt; mso-yfti-irow: 3;&quot;&gt;
  &lt;td rowspan=&quot;2&quot; style=&quot;background: #FFF2CC; border-top: none; border: solid windowtext 1.0pt; height: 16.2pt; mso-background-themecolor: accent4; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 54.65pt;&quot; width=&quot;73&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Admin&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: .75in;&quot; width=&quot;72&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Type IAIN&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 117.0pt;&quot; width=&quot;156&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;14 days before submission&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: .75in;&quot; width=&quot;72&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;N/A&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td rowspan=&quot;2&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 49.5pt;&quot; width=&quot;66&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;AR&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td rowspan=&quot;2&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 139.5pt;&quot; width=&quot;186&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;Pa9&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; text-align: center;&quot;&gt;
&lt;span class=&quot;A10&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Up to 1 year before submission&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td rowspan=&quot;2&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 56.15pt;&quot; width=&quot;75&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;N/A&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 16.2pt; mso-yfti-irow: 4;&quot;&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: .75in;&quot; width=&quot;72&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;Pa9&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; text-align: center;&quot;&gt;
&lt;span class=&quot;A10&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Type IA&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 117.0pt;&quot; width=&quot;156&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Up to 1 year before submission&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: .75in;&quot; width=&quot;72&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;N/A&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 16.2pt; mso-yfti-irow: 5;&quot;&gt;
  &lt;td rowspan=&quot;2&quot; style=&quot;background: #FFF2CC; border-top: none; border: solid windowtext 1.0pt; height: 16.2pt; mso-background-themecolor: accent4; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 54.65pt;&quot; width=&quot;73&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Minor&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td rowspan=&quot;2&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: .75in;&quot; width=&quot;72&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;Pa9&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; text-align: center;&quot;&gt;
&lt;span class=&quot;A10&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Type IB&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td rowspan=&quot;2&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 117.0pt;&quot; width=&quot;156&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Up to 3 months after submission*&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td rowspan=&quot;2&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: .75in;&quot; width=&quot;72&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;30 days&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 49.5pt;&quot; width=&quot;66&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;CBE-0&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 139.5pt;&quot; width=&quot;186&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;On receipt of submission by FDA&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 56.15pt;&quot; width=&quot;75&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;N/A&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 16.2pt; mso-yfti-irow: 6;&quot;&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 49.5pt;&quot; width=&quot;66&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;CBE-30&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 139.5pt;&quot; width=&quot;186&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;30 days after receipt of submission&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 56.15pt;&quot; width=&quot;75&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;6 months&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 16.2pt; mso-yfti-irow: 7;&quot;&gt;
  &lt;td style=&quot;background: #FFF2CC; border-top: none; border: solid windowtext 1.0pt; height: 16.2pt; mso-background-themecolor: accent4; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 54.65pt;&quot; width=&quot;73&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Major&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: .75in;&quot; width=&quot;72&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;Pa9&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; text-align: center;&quot;&gt;
&lt;span class=&quot;A10&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Type II&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 117.0pt;&quot; width=&quot;156&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Up to 6 months after submission*&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: .75in;&quot; width=&quot;72&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;30 days&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 49.5pt;&quot; width=&quot;66&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;PAS&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 139.5pt;&quot; width=&quot;186&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;Up to 6 months after submission*&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 16.2pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 56.15pt;&quot; width=&quot;75&quot;&gt;
  &lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-align: center; text-autospace: none;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;4 months&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 8.4pt; mso-yfti-irow: 8; mso-yfti-lastrow: yes;&quot;&gt;
  &lt;td colspan=&quot;7&quot; style=&quot;border-top: none; border: solid windowtext 1.0pt; height: 8.4pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 524.8pt;&quot; width=&quot;700&quot;&gt;
  &lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -4.5pt; margin-right: -7.45pt; margin-top: 0in; mso-layout-grid-align: none; text-autospace: none;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;*The noted anticipated dates are
  based on experience with submitting variations to the relevant agencies and
  incorporate the time taken for validation, application assessment,
  applicant’s response to questions (clock stop) and assessment of responses.&lt;/span&gt;&lt;/i&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;span style=&quot;font-family: &amp;quot;Arial&amp;quot;,sans-serif; font-size: 10.5pt; line-height: 115%; mso-ansi-language: EN-US; mso-bidi-language: GU; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-fareast-theme-font: minor-latin;&quot;&gt;&lt;br clear=&quot;all&quot; style=&quot;mso-special-character: line-break; page-break-before: always;&quot; /&gt;
&lt;/span&gt;

&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 115%; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;br /&gt;&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/5621656419376214062/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/06/comparison-of-eu-and-us-variation.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/5621656419376214062'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/5621656419376214062'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/06/comparison-of-eu-and-us-variation.html' title='Comparison of EU and US variation requirements'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-4518623544671312427</id><published>2020-06-21T16:54:00.000+05:30</published><updated>2020-06-21T18:12:27.515+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="Regulatory Agencies"/><title type='text'>European (EU) Variation Requirements</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;What
is Variation:&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Variation means any
amendment to the terms of the decision granting the marketing authorization as
well as any change to the summary of product characteristics and the documents
forming the basis for an authorization to market a medicinal product.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;European Commission has
classified the variation type as type IA/IAIN, type IB and type II.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2020/06/european-eu-variation-requirements.html&quot;&gt;&lt;img alt=&quot;European (EU) Variation Requirements&quot; height=&quot;283&quot; src=&quot;data:image/png;base64,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&quot; title=&quot;European (EU) Variation Requirements&quot; width=&quot;640&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Type IA/IAIN (do and
tell):&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Changes that fall under
this category are commonly referred to as “do and tell” variations because the applicant is required to implement the change and then notify the agency of the
details.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;This level of variation
is reserved for administrative changes that are anticipated to have no impact
on the quality, safety or efficacy of a product.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Variations that can be
submitted as Type IA must be implemented and then the required submission made
within 12 months of the implementation date.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&amp;nbsp;For changes that
are categorized as Type IAIN the applicant must notify the agency within 14
days of implementation and for a single product multiples variation can be made
at the same time, as long as all of them fall within the required submission
deadline.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Type IB (tell, wait and
do):&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Minor variations that
require assessment of supporting data and are anticipated to potentially have
an impact on product quality, safety or efficacy are classified as Type IB and
these are also referred to as “tell, wait and do” variations.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Type IB variations are
minor variations, which are neither a type IA variation, a type II variation
nor an extension.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;The applicant must make
the submission, including all required supporting data, and await agency
approval before implementing the change.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;The process follows a
defined assessment period of 30 days, but with agency questions it can often
take up to 03 months.&lt;/span&gt;&lt;br /&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Type II:&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A major change to a
marketing authorization that may have a significant impact on the quality,
safety or efficacy of a medicine, but does not involve a change to the active
substance, its strength or the route of administration. Type II variations
require a formal approval.&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;They require
considerable supporting documentation and must be assessed and signed off by an
appropriately qualified expert in their respected field before being submitted.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Anticipated implementation
time of Type II is Up to 6 months after submission.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;What are Major Changes:&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Where notable
alterations to product registration are required, these are expected to have an
impact on a product’s quality and efficacy and as such are tightly controlled,
requiring in-depth assessment and review.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;The Marketing
authorization Holder (MAH) must demonstrate that the product will retain the
same level of quality and efficacy. Comparative data is a significant
requirement for such changes and must reliably show the proposed changes do not
impair product quality and Assessment times for such variations are often much
longer, as agencies carefully review submissions and frequently make requests
for additional data and answers to questions and concerns.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;What are Line
Extensions:&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Certain changes which
affect the fundamentals of the terms of the authorization cannot be granted via
a variation and are submitted as an “extension application”:&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Example: changes to the
active substance(s); changes to strength, pharmaceutical form and route of
administration. The invented name will remain the same for the “extension”.&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;table border=&quot;1&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;MsoTable15List3Accent2&quot; style=&quot;border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-border-insideh: .5pt solid windowtext; mso-border-insidev: .5pt solid windowtext; mso-padding-alt: 0in 5.4pt 0in 5.4pt; mso-yfti-tbllook: 1184; width: 624px;&quot;&gt;
 &lt;tbody&gt;
&lt;tr style=&quot;height: 19.5pt; mso-yfti-firstrow: yes; mso-yfti-irow: -1; mso-yfti-lastfirstrow: yes;&quot;&gt;
  &lt;td style=&quot;background: #ED7D31; border-bottom: none; border-left: solid windowtext 1.0pt; border-right: none; border-top: solid windowtext 1.0pt; height: 19.5pt; mso-background-themecolor: accent2; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 67.25pt;&quot; width=&quot;90&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; mso-yfti-cnfc: 517; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Variation&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;background: #ED7D31; border: solid windowtext 1.0pt; height: 19.5pt; mso-background-themecolor: accent2; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 103.5pt;&quot; width=&quot;138&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; mso-yfti-cnfc: 1; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Type&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;background: #ED7D31; border-left: none; border: solid windowtext 1.0pt; height: 19.5pt; mso-background-themecolor: accent2; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 189.0pt;&quot; width=&quot;252&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; mso-yfti-cnfc: 1; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Anticipated implementation date&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;background: #ED7D31; border-left: none; border: solid windowtext 1.0pt; height: 19.5pt; mso-background-themecolor: accent2; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 1.5in;&quot; width=&quot;144&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; mso-yfti-cnfc: 1; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Guideline approval timeline&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 38.25pt; mso-yfti-irow: 0;&quot;&gt;
  &lt;td style=&quot;background: white; border: solid windowtext 1.0pt; height: 38.25pt; mso-background-themecolor: background1; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 67.25pt;&quot; width=&quot;90&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Admin&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 38.25pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 103.5pt;&quot; width=&quot;138&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Type
  IAIN &amp;amp; IA&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 38.25pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 189.0pt;&quot; width=&quot;252&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;14
  days before implementation and up to 1 year before submission&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 38.25pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 1.5in;&quot; width=&quot;144&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Not
  applicable&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 19.5pt; mso-yfti-irow: 1;&quot;&gt;
  &lt;td style=&quot;background: white; border-top: none; border: solid windowtext 1.0pt; height: 19.5pt; mso-background-themecolor: background1; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 67.25pt;&quot; width=&quot;90&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Minor&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 19.5pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 103.5pt;&quot; width=&quot;138&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Type IB&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 19.5pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 189.0pt;&quot; width=&quot;252&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Up to 3 months after submission&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 19.5pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 1.5in;&quot; width=&quot;144&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;30 days&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 19.5pt; mso-yfti-irow: 2; mso-yfti-lastrow: yes;&quot;&gt;
  &lt;td style=&quot;background: white; border-top: none; border: solid windowtext 1.0pt; height: 19.5pt; mso-background-themecolor: background1; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 67.25pt;&quot; width=&quot;90&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Major&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 19.5pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 103.5pt;&quot; width=&quot;138&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Type
  II&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 19.5pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 189.0pt;&quot; width=&quot;252&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Up
  to 6 months after submission&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 19.5pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 1.5in;&quot; width=&quot;144&quot;&gt;&lt;div align=&quot;center&quot; class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: -1.5pt; margin-right: -8.25pt; margin-top: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;60
  days&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; margin-bottom: 13.2pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;br /&gt;&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/4518623544671312427/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/06/european-eu-variation-requirements.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/4518623544671312427'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/4518623544671312427'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/06/european-eu-variation-requirements.html' title='European (EU) Variation Requirements'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-2697744603506860057</id><published>2020-06-04T20:42:00.002+05:30</published><updated>2020-06-04T20:43:18.234+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="ICH Guidelines"/><title type='text'>Classification of Impurities as per ICH guidelines</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Impurities can be classified into the following
categories:&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;margin-left: 76.5pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;margin-left: 76.5pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Organic impurities (process- and drug-related) &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin-left: 76.5pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin-left: 76.5pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Inorganic impurities &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;margin-left: 76.5pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;margin-left: 76.5pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Residual solvents&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;margin-left: 76.5pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;margin-left: 76.5pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2020/06/Classification-of-Impurities-as-per-ICH-guidelines.html&quot;&gt;&lt;img alt=&quot;Classification of Impurities as per ICH guidelines&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_Un-mdgLOIlmm-m6buey_0Fo5GEJgGw_7F8HH4LXeLX_DimcNbTX89SR-yILhJx_NAjaszYWBrTO5L8Fo0a5pPmV85uxQbMqu06Ogeu1oRuOopdlFhjJxlqmWW2Qj01-PLhcF8Sq5z_AL/s400/Pharmaceutical+Development+As+Per+ICH+Guidelines.jpg&quot; title=&quot;Classification of Impurities as per ICH guidelines&quot; /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Organic impurities&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt; can
arise during the manufacturing process and/or storage of the new drug
substance. They can be identified or unidentified, volatile or non-volatile,
and include:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Starting materials&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;By-products&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Intermediates&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Degradation products&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Reagents, ligands and catalysts&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Inorganic impurities&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt; can
result from the manufacturing process. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;They are normally known and identified and include: &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Reagents, ligands and catalysts &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Heavy metals or other residual metals &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Inorganic salts &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;margin-left: 81pt; text-align: justify; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Other materials (e.g., filter aids, charcoal)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Solvents are inorganic or organic liquids used as vehicles
for the preparation of solutions or suspensions in the synthesis of a new drug
substance. Since these are generally of known toxicity, the selection of
appropriate controls is easily accomplished.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Classification of Residual Solvents by Risk
Assessment&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Class 1 solvents: Solvents to be avoided&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Known human carcinogens, strongly suspected human
carcinogens, and environmental hazards.&lt;/span&gt;&lt;/div&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Solvents in Class 1 should not be employed in the manufacture
of drug substances, excipients, and drug products because of their unacceptable
toxicity or their deleterious environmental effect.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;However, if their use is unavoidable to produce a drug
product with a significant therapeutic advance, then their levels should be
restricted as shown in, unless otherwise justified.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Class 1 solvents in pharmaceutical products &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;(solvents
that should be avoided).&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div style=&quot;text-align: center;&quot;&gt;
&lt;table border=&quot;1&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;MsoTable15List4Accent2&quot; style=&quot;border-collapse: collapse; border: none; text-align: justify;&quot;&gt;
 &lt;tbody&gt;
&lt;tr&gt;
  &lt;td style=&quot;background: #ED7D31; border: solid windowtext 1.0pt; mso-background-themecolor: accent2; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 161.75pt;&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 5; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: white; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Solvent&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;background: #ED7D31; border-left: none; border: solid windowtext 1.0pt; mso-background-themecolor: accent2; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 121.5pt;&quot; width=&quot;162&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 1; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: white; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Concentration limit&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 1; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: white; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;(ppm)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;background: #ED7D31; border-left: none; border: solid windowtext 1.0pt; mso-background-themecolor: accent2; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 2.25in;&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 1; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: white; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Concern&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr&gt;
  &lt;td style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 161.75pt;&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Benzene&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 121.5pt;&quot; width=&quot;162&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;2&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 2.25in;&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Carcinogen&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr&gt;
  &lt;td style=&quot;border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 161.75pt;&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Carbon tetrachloride&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 121.5pt;&quot; width=&quot;162&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;4&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 2.25in;&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Toxic and environmental hazard&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr&gt;
  &lt;td style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 161.75pt;&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1,2-Dichloroethane&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 121.5pt;&quot; width=&quot;162&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;5&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 2.25in;&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Toxic&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr&gt;
  &lt;td style=&quot;border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 161.75pt;&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1,1-Dichloroethene&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 121.5pt;&quot; width=&quot;162&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;8&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 2.25in;&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Toxic&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr&gt;
  &lt;td style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 161.75pt;&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1,1,1-Trichloroethane&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 121.5pt;&quot; width=&quot;162&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1500&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 2.25in;&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Environmental hazard&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Class 2 solvents: Solvents to be limited &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Non-genotoxic animal carcinogens or possible causative
agents of other irreversible toxicity such as neurotoxicity or teratogenicity.
Solvents suspected of other significant but reversible toxicities. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Solvents in should be limited in pharmaceutical products
because of their inherent toxicity.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;PDEs are given to the nearest 0.1 mg/day, and
concentrations are given to the nearest 10 ppm.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Class 2 solvents in pharmaceutical products.&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div style=&quot;text-align: center;&quot;&gt;
&lt;table border=&quot;1&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;MsoTable15List4Accent2&quot; style=&quot;border-collapse: collapse; border: none; text-align: justify; width: 435px;&quot;&gt;
 &lt;tbody&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-firstrow: yes; mso-yfti-irow: -1; mso-yfti-lastfirstrow: yes;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #ED7D31; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 5; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: white; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Solvent&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;color: white; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #ED7D31; border-left: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 1; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: white; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;PDE (mg/day)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #ED7D31; border-left: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 1; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: white; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Concentration limit
  (ppm)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 0;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Acetonitrile&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;4.1&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;410&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 1;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Chlorobenzene&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;3.6&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;360&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 2;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Chloroform&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;0.6&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;60&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 3;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Cumene1&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;0.7&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;70&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 4;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Cyclohexane&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;38.8&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;3880&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 5;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1,2-Dichloroethene&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;18.7&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1870&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 6;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Dichloromethane&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;6&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;600&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 7;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1,2-Dimethoxyethane&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;100&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 8;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;N,N-Dimethylacetamide&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;10.9&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1090&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 9;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;N,N-Dimethylformamide&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;8.8&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;880&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 10;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1,4-Dioxane&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;3.8&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;380&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 11;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;2-Ethoxyethanol&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1.6&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;160&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 12;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Ethyleneglycol&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;6.2&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;620&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 13;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Formamide&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;2.2&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;220&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 14;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Hexane&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;2.9&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;290&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 15;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Methanol&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;30&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;3000&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 16;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;2-Methoxyethanol&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;0.5&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;50&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 17;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Methylbutyl ketone&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;0.5&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;50&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 18;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Methylcyclohexane&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;11.8&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1180&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 19;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Methylisobutylketone2&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;45&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;4500&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 20;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;N-Methylpyrrolidone3&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;5.3&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #FBE4D5; border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent2; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;530&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 21; mso-yfti-lastrow: yes;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid windowtext 1.0pt; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 111.95pt;&quot; width=&quot;149&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Nitromethane&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.0pt;&quot; width=&quot;115&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;0.5&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 128.0pt;&quot; width=&quot;171&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;50&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Class 3 solvents: Solvents with low toxic
potential &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Solvents with low toxic potential to man; no health-based
exposure limit is needed. Class 3 solvents have PDEs of 50 mg or more per day.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Solvents in Class 3 may be regarded as less toxic and of
lower risk to human health.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Class 3 includes no solvent known as a human health hazard
at levels normally accepted in pharmaceuticals.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;However, there are no long-term toxicity or carcinogenicity
studies for many of the solvents in Class 3.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Class 3 solvents which should be limited by GMP
or other quality-based requirements.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div style=&quot;text-align: center;&quot;&gt;
&lt;table border=&quot;1&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;MsoTable15Grid6ColorfulAccent3&quot; style=&quot;border-collapse: collapse; border: none; text-align: justify; width: 336px;&quot;&gt;
 &lt;tbody&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-firstrow: yes; mso-yfti-irow: -1; mso-yfti-lastfirstrow: yes;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid #C9C9C9 1.5pt; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-alt: solid #C9C9C9 1.5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-bottom-themetint: 153; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 129.75pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 5; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Acetic acid&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid #C9C9C9 1.5pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: solid #C9C9C9 1.0pt; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-alt: solid #C9C9C9 1.5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 122.0pt;&quot; valign=&quot;top&quot; width=&quot;163&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 1; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Heptane&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 0;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 129.75pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Acetone&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 122.0pt;&quot; valign=&quot;top&quot; width=&quot;163&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Isobutyl acetate&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 1;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 129.75pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Anisole&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 122.0pt;&quot; valign=&quot;top&quot; width=&quot;163&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Isopropyl acetate&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 2;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 129.75pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1-Butanol&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 122.0pt;&quot; valign=&quot;top&quot; width=&quot;163&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Methyl acetate&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 3;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 129.75pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;2-Butanol&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 122.0pt;&quot; valign=&quot;top&quot; width=&quot;163&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;3-Methyl-1-butanol&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 4;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 129.75pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Butyl acetate&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 122.0pt;&quot; valign=&quot;top&quot; width=&quot;163&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Methylethyl ketone&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 5;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 129.75pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;tert-Butylmethyl ether&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 122.0pt;&quot; valign=&quot;top&quot; width=&quot;163&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;2-Methyl-1-propanol&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 6;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 129.75pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Dimethyl sulfoxide&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 122.0pt;&quot; valign=&quot;top&quot; width=&quot;163&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Pentane&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 7;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 129.75pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Ethanol&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 122.0pt;&quot; valign=&quot;top&quot; width=&quot;163&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1-Pentanol&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 8;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 129.75pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Ethyl acetate&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 122.0pt;&quot; valign=&quot;top&quot; width=&quot;163&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1-Propanol&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 9;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 129.75pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Ethyl ether&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 122.0pt;&quot; valign=&quot;top&quot; width=&quot;163&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;2-Propanol&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 10;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 129.75pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Ethyl formate&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 122.0pt;&quot; valign=&quot;top&quot; width=&quot;163&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Propyl acetate&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 11; mso-yfti-lastrow: yes;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 129.75pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Formic acid&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 122.0pt;&quot; valign=&quot;top&quot; width=&quot;163&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: center;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Triethylamine&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Solvents for which No Adequate Toxicological
Data was Found&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;The following solvents may also be of interest to
manufacturers of excipients, drug substances, or drug products.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;However, no adequate toxicological data on which to base a
PDE was found.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Manufacturers should supply justification for residual
levels of these solvents in pharmaceutical products.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div style=&quot;text-align: center;&quot;&gt;
&lt;table border=&quot;1&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;MsoTable15Grid6ColorfulAccent3&quot; style=&quot;border-collapse: collapse; border: none; text-align: justify; width: 444px;&quot;&gt;
 &lt;tbody&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-firstrow: yes; mso-yfti-irow: -1; mso-yfti-lastfirstrow: yes;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid #C9C9C9 1.5pt; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-alt: solid #C9C9C9 1.5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-bottom-themetint: 153; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 161.75pt;&quot; valign=&quot;top&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 5;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1,1-Diethoxypropane&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid #C9C9C9 1.5pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: solid #C9C9C9 1.0pt; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-alt: solid #C9C9C9 1.5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 171.0pt;&quot; valign=&quot;top&quot; width=&quot;228&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 1;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Methylisopropyl ketone&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 0;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 161.75pt;&quot; valign=&quot;top&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;1,1-Dimethoxymethane&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 171.0pt;&quot; valign=&quot;top&quot; width=&quot;228&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Methyltetrahydrofuran&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 1;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 161.75pt;&quot; valign=&quot;top&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;2,2-Dimethoxypropane&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 171.0pt;&quot; valign=&quot;top&quot; width=&quot;228&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Petroleum ether&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 2;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 161.75pt;&quot; valign=&quot;top&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 68;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Isooctane&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;background: #EDEDED; border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 171.0pt;&quot; valign=&quot;top&quot; width=&quot;228&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 64;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Trichloroacetic acid&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr style=&quot;height: 15.0pt; mso-yfti-irow: 3; mso-yfti-lastrow: yes;&quot;&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-top: none; border: solid #C9C9C9 1.0pt; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-themecolor: accent3; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 161.75pt;&quot; valign=&quot;top&quot; width=&quot;216&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-yfti-cnfc: 4;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Isopropyl ether&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td nowrap=&quot;&quot; style=&quot;border-bottom: solid #C9C9C9 1.0pt; border-left: none; border-right: solid #C9C9C9 1.0pt; border-top: none; height: 15.0pt; mso-border-alt: solid #C9C9C9 .5pt; mso-border-bottom-themecolor: accent3; mso-border-bottom-themetint: 153; mso-border-left-alt: solid #C9C9C9 .5pt; mso-border-left-themecolor: accent3; mso-border-left-themetint: 153; mso-border-right-themecolor: accent3; mso-border-right-themetint: 153; mso-border-themecolor: accent3; mso-border-themetint: 153; mso-border-top-alt: solid #C9C9C9 .5pt; mso-border-top-themecolor: accent3; mso-border-top-themetint: 153; padding: 0in 5.4pt 0in 5.4pt; width: 171.0pt;&quot; valign=&quot;top&quot; width=&quot;228&quot;&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Trifluoroacetic acid&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/2697744603506860057/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/06/Classification-of-Impurities-as-per-ICH-guidelines.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/2697744603506860057'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/2697744603506860057'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/06/Classification-of-Impurities-as-per-ICH-guidelines.html' title='Classification of Impurities as per ICH guidelines'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_Un-mdgLOIlmm-m6buey_0Fo5GEJgGw_7F8HH4LXeLX_DimcNbTX89SR-yILhJx_NAjaszYWBrTO5L8Fo0a5pPmV85uxQbMqu06Ogeu1oRuOopdlFhjJxlqmWW2Qj01-PLhcF8Sq5z_AL/s72-c/Pharmaceutical+Development+As+Per+ICH+Guidelines.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-4333248070968702019</id><published>2020-06-02T20:54:00.000+05:30</published><updated>2020-06-03T05:53:49.432+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Validation/Calibration"/><title type='text'>Weighing balance calibration in Pharmaceutical</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: #333333; font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;;&quot;&gt;Preparations before calibration&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;color: #333333; font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-fareast-font-family: &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: #333333; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Before you can start the calibration of the weighing instrument,
you should clarify a few things and get prepared.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: #333333; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;You should find out the technical characteristics of the
weighing instrument (max weight, d value), the accuracy requirement (max error
allowed and uncertainty) and what to do if the calibration fails (adjustment).&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: #333333; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Typically, the whole measurement range is calibrated and the
calibration is performed in the location where the instrument is being used.
Make sure you have enough weights for the calibration procedure available.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: #333333; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;The weighing instrument should be switched on at least 30
minutes before the calibration. The temperature of the weights should be
stabilized to the same temperature where the calibration is to be done.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: #333333; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;The weighing instrument should be at a horizontal level,
especially for small and accurate weighing instruments. Perform a few pre-tests
by placing weights close to the maximum of the range on the instrument and to
ensure it works normally.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: #333333; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;In case the weighing instrument fails in calibration and it is
adjusted, you should make an “as found” calibration before an adjustment and an
“as left” calibration after adjustment.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;background: white; line-height: normal; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: #333333; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;In the Pharmaceutical industry
calibration of weighing balance is done on a monthly basis to check the accuracy
of the balance. While performing weighing balance calibration check the following
parameters:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;·&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Accuracy&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;·&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Reproducibility&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;·&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Eccentricity&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;Accuracy:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;Verify the balances for
accuracy with the minimum weight (least count×100 ),5%, 20%, 50% and 90% the capacity of respective balances. Record the displayed weight in respective
monthly calibration formats.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;/span&gt;&lt;br /&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt; line-height: 107%;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Tolerance:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;The variation if any
should be ± least count of the balance for ± 0.2 % of the &lt;b&gt;certified value of the standard weight &lt;/b&gt;used whenever is higher and for analytical balance, the
variation should be ± least count of the balance or ± 0.1 % of the &lt;b&gt;certificate
value of standard weight &lt;/b&gt;used whenever it is higher.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;Reproducibility:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Check the
Reproducibility by using the minimum &lt;i&gt;standard weight of balance capacity&lt;/i&gt;.
place the weight in the middle of the weighing pen and observe the displayed
value. repeat the procedure &lt;b&gt;9 times &lt;/b&gt;for the standard weight and record
the reading. Calculate % RSD for both the standard weight by the following
formula.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2020/06/weighing-balance-calibration-in-pharmaceuticals.html&quot;&gt;&lt;img alt=&quot;Weighing balance calibration in Pharmaceutical&quot; height=&quot;112&quot; src=&quot;https://cdn.kastatic.org/googleusercontent/N8xzWFc6eo0XBHEXZjz1SwvLSnPezvhTRF1P17kdjUG_tnJivGKkyCxbwVe4MZ0-USOxIZBohgcjdi8e7Z4Hswcqfw&quot; title=&quot;Weighing balance calibration in Pharmaceutical&quot; width=&quot;200&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;where x= individual
value&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;x̄= mean of the
individual value&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;n= number of values.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;RSD= SD*100/ X&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Acceptance criteria: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;%RSD not more than 2.0
%. Record the observations in monthly calibration record as per “monthly calibration
record of weighing balance”.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;Eccentricity:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Take the minimum weight and
keep at on specified position as shown below calculate %RSD by following the formula is specified above.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2020/06/weighing-balance-calibration-in-pharmaceuticals.html&quot;&gt;&lt;img alt=&quot;Weighing balance calibration in Pharmaceutical&quot; height=&quot;158&quot; src=&quot;https://cdn2.hubspot.net/hub/2203666/hubfs/Beamex_blog_pictures/Eccentricity%20test%20picture.jpg?width=1200&amp;amp;name=Eccentricity%20test%20picture.jpg&quot; title=&quot;Weighing balance calibration in Pharmaceutical&quot; width=&quot;400&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Acceptance criteria:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;% RSD not more than 2.0
%. Record the details of calibration in labels with Marker Pen. write the
identification number of the standard weight used during verification and
calibration in the designated place of verification and calibration records.
Calibration record shall be verified by&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;a quality assurance by
putting &lt;b&gt;“reviewed by quality assurance” &lt;/b&gt;stamp along with initials and
date. calibration of analytical balance in the quality control department shall
be done as per their respective SOP.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;Calibration of balances by external agency:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Internal calibration
(software calibration) of weighing balances shall be done by external agencies.
calibration certificate received from an external agency shall be reviewed
comprising the detail of balance and calibration summary.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;Action to be taken if out of
calibration:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;If the balance is out
of calibration to refer sop &lt;b&gt;“handling of out of calibration” &lt;/b&gt;and rise
deviation as per SOP “handling of deviation” and a fix the label “out of
calibration” as per SOP (status labeling) and inform to Department Head of
Investigation.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Raise maintenance memo
and inform the engineering department for rectification action. if required
take a balance of configuration from another section and department for
carrying out the weighing activity. In Such situations, carry out Daily
verification of transferred balance and used for Weighing. if the parameter of
Daily verification does not meet with the specification, monthly calibration
should be done. Once rectification of the balance is done, calibrate the
balance and record the same in respective calibration records. the balance
shall be released for further use only on satisfactory closure of the deviation
with detail result of Investigation.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-layout-grid-align: none; text-align: justify; text-autospace: none;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;br /&gt;&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/4333248070968702019/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/06/weighing-balance-calibration-in-pharmaceuticals.html#comment-form' title='2 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/4333248070968702019'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/4333248070968702019'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/06/weighing-balance-calibration-in-pharmaceuticals.html' title='Weighing balance calibration in Pharmaceutical'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><thr:total>2</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-4810993433298523419</id><published>2020-05-25T07:04:00.002+05:30</published><updated>2020-05-25T07:05:52.953+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="ICH Guidelines"/><title type='text'>Pharmaceutical Development As Per ICH Guidelines</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;INTRODUCTION&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The
Pharmaceutical Development section provides an opportunity to present the
knowledge gained through the application of scientific approaches and quality
risk management to the development of a product and its manufacturing process.
It is first produced for the original marketing application and can be updated
to support new knowledge gained over the lifecycle of a product. The
Pharmaceutical Development section is intended to provide a comprehensive
understanding of the product and manufacturing process for reviewers and
inspectors. The guideline also indicates areas where the demonstration of
greater understanding of pharmaceutical and manufacturing sciences can create a
basis for flexible regulatory approaches. The degree of regulatory flexibility
is predicated on the level of relevant scientific knowledge provided.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;br /&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2020/05/pharmaceutical-development-as-per-ich-guideline.html&quot;&gt;&lt;img alt=&quot;Pharmaceutical Development As Per ICH Guidelines&quot; border=&quot;0&quot; data-original-height=&quot;162&quot; data-original-width=&quot;480&quot; height=&quot;135&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_Un-mdgLOIlmm-m6buey_0Fo5GEJgGw_7F8HH4LXeLX_DimcNbTX89SR-yILhJx_NAjaszYWBrTO5L8Fo0a5pPmV85uxQbMqu06Ogeu1oRuOopdlFhjJxlqmWW2Qj01-PLhcF8Sq5z_AL/s400/Pharmaceutical+Development+As+Per+ICH+Guidelines.jpg&quot; title=&quot;Pharmaceutical Development As Per ICH Guidelines&quot; width=&quot;400&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;PHARMACEUTICAL
DEVELOPMENT&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The
aim of pharmaceutical development is to design a quality product and its the manufacturing process to consistently deliver the intended performance of the
product. The information and knowledge gained from pharmaceutical development
studies and manufacturing experience provide scientific understanding to
support the establishment of the design space, specifications, and
manufacturing controls. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;Information
from pharmaceutical development studies can be a basis for quality risk
management. It is important to recognize that quality cannot be tested into
products; i.e., quality should be built in by design. Changes in formulation
and manufacturing processes during development and lifecycle management should
be looked upon as opportunities to gain additional knowledge and further
support the establishment of the design space. Similarly, the inclusion of relevant
knowledge gained from experiments giving unexpected results can also be useful.
Design space is proposed by the applicant and is subject to regulatory
assessment and approval. Working within the design space is not considered as a
change. Movement out of the design space is considered to be a change and would
normally initiate a regulatory post approval change process. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The
Pharmaceutical Development section should describe the knowledge that
establishes that the type of dosage form selected and the formulation proposed
are suitable for the intended use. This section should include sufficient
information in each part to provide an understanding of the development of the
drug product and its manufacturing process. Summary tables and graphs are
encouraged where they add clarity and facilitate a review. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;At
a minimum, those aspects of drug substances, excipients, container closure
systems, and manufacturing processes that are critical to product quality
should be determined and control strategies justified. Critical formulation
attributes and process parameters are generally identified through an
assessment of the extent to which their variation can have an impact on the
quality of the drug product.&lt;/span&gt;&lt;/div&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;In
addition, the applicant can choose to conduct pharmaceutical development
studies that can lead to an enhanced knowledge of product performance over a wider range of material attributes, processing options and process parameters.
Inclusion of this additional information in this section provides an
opportunity to demonstrate a higher degree of understanding of the material
attributes, manufacturing processes and their controls. This scientific
understanding facilitates the establishment of an expanded design space. In these
situations, opportunities exist to develop more flexible regulatory approaches,
for example, to facilitate: &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;•
Risk-based regulatory decisions (reviews and inspections); &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;•
Manufacturing process improvements, within the approved design space described
in the dossier, without further regulatory review; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;•
Reduction of post-approval submissions; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;•
Real-time quality control, leading to a reduction of end-product release
testing. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;To
realise this flexibility, the applicant should demonstrate an enhanced
knowledge of product performance over a range of material attributes,
manufacturing process options and process parameters. This understanding can be
gained by application of, for example, formal experimental designs, process
analytical technology (PAT), and/or prior knowledge. Appropriate use of quality
risk management principles can be helpful in prioritising the additional
pharmaceutical development studies to collect such knowledge.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;A.
Components of the Drug Product&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;b&gt;1.
Drug Substance&lt;/b&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The
physicochemical and biological properties of the drug substance that can influence
the performance of the drug product and its manufacturability, or were
specifically designed into the drug substance (e.g., solid state properties),
should be identified and discussed. Examples of physicochemical and biological
properties that might need to be examined include solubility, water content,
particle size, crystal properties, biological activity, and permeability. These
properties could be interrelated and might need to be considered in
combination. To evaluate the potential effect of drug substance physicochemical
properties on the performance of the drug product, studies on drug product
might be warranted.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;b&gt;2.
Excipients&lt;/b&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The
excipients chosen, their concentration, and the characteristics that can
influence the drug product performance (e.g., stability, bioavailability) or
manufacturability should be discussed relative to the respective function of
each excipient. This should include all substances used in the manufacture of
the drug product, whether they appear in the finished product or not (e.g.,
processing aids).&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;B.
Drug Product&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;b&gt;1.
Formulation Development&lt;/b&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;A
summary should be provided describing the development of the formulation,
including identification of those attributes that are critical to the quality
of the drug product, taking into consideration intended usage and route of
administration. Information from formal experimental designs can be useful in
identifying critical or interacting variables that might be important to ensure
the quality of the drug product. The summary should highlight the evolution of
the formulation design from initial concept up to the final design. This
summary should also take into consideration the choice of drug product
components (e.g., the properties of the drug substance, excipients, container
closure system, any relevant dosing device), the manufacturing process, and, if
appropriate, knowledge gained from the development of similar drug product(s). &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;b&gt;2.
Overages&lt;/b&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;In
general, use of an overage of a drug substance to compensate for degradation
during manufacture or a product’s shelf life, or to extend shelf life, is
discouraged. Any overages in the manufacture of the drug product, whether they
appear in the final formulated product or not, should be justified considering
the safety and efficacy of the product. Information should be provided on the &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;1)
amount of overage, &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;2)
reason for the overage (e.g., to compensate for expected and documented
manufacturing losses),&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;3)
justification for the amount of overage. The overage should be included in the
amount of drug substance listed in the batch formula.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;b&gt;3.
Physicochemical and Biological Properties&lt;/b&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The
physicochemical and biological properties relevant to the safety, performance
or manufacturability of the drug product should be identified and discussed.
This includes the physiological implications of drug substance and formulation
attributes. Studies could include, for example, the development of a test for
respirable fraction of an inhaled product. Similarly, information supporting
the selection of dissolution vs. disintegration testing, or other means to
assure drug release, and the development and suitability of the chosen test,
could be provided in this section. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;C.
Manufacturing Process Development&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The
selection, the control, and any improvement of the manufacturing process (i.e.,
intended for commercial production batches) should be explained. It is
important to consider the critical formulation attributes, together with the
available manufacturing process options, in order to address the selection of
the manufacturing process and confirm the appropriateness of the components. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;Appropriateness
of the equipment used for the intended products should be discussed. Process
development studies should provide the basis for process improvement, process
validation, continuous process verification (where applicable), and any process
control requirements. Where appropriate, such studies should address
microbiological as well as physical and chemical attributes. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The
knowledge gained from process development studies can be used, as appropriate,
to justify the drug product specification. The manufacturing process
development programme or process improvement programme should identify any
critical process parameters that should be monitored or controlled (e.g.,
granulation end point) to ensure that the product is of the desired quality.
For those products intended to be sterile an appropriate method of
sterilization for the drug product and primary packaging material should be
chosen and the choice justified. Significant differences between the
manufacturing processes used to produce batches for pivotal clinical trials
(safety, efficacy, bioavailability, bioequivalence) or primary stability
studies and the process should be discussed. The discussion should summarise the
influence of the differences on the performance, manufacturability and quality
of the product. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;An
assessment of the ability of the process to reliably produce a product of the intended
quality (e.g., the performance of the manufacturing process under different
operating conditions, at different scales, or with different equipment) can be
provided. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;D.
Container Closure System&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The
choice and rationale for selection of the container closure system for the
commercial product should be discussed. Consideration should be given to the
intended use of the drug product and the suitability of the container closure
system for storage and transportation (shipping), including the storage and
shipping container for bulk drug product, where appropriate. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The
choice of materials for primary packaging should be justified. The discussion
should describe studies performed to demonstrate the integrity of the container
and closure. A possible interaction between product and container or label
should be considered. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The
choice of primary packaging materials should consider, e.g., choice of
materials, protection from moisture and light, compatibility of the materials
of construction with the dosage form (including sorption to container and
leaching), and safety of materials of construction. Justification for secondary
packaging materials should be included, when relevant. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;If
a dosing device is used (e.g., dropper pipette, pen injection device, dry
powder inhaler), it is important to demonstrate that a reproducible and
accurate dose of the product is delivered under testing conditions which, as
far as possible, simulate the use of the product.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;E.
Microbiological Attributes&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;Where
appropriate, the microbiological attributes of the drug product should be
discussed. The discussion should include, for example: &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;•
The rationale for performing or not performing microbial limits testing for non
sterile drug products (e.g., Decision Tree #8 in ICH Q6A Specifications: Test
Procedures and Acceptance Criteria for New Drug Substances and New Drug
Products: Chemical Substances and ICH Q6B Specifications: Test Procedures and
Acceptance Criteria for Biotechnology/Biological Products); &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;•
The selection and effectiveness of preservative systems in products containing
antimicrobial preservative or the antimicrobial effectiveness of products that
are inherently antimicrobial; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;•
For sterile products, the integrity of the container closure system as it
relates to preventing microbial contamination. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;Although
chemical testing for preservative content is the attribute normally included in
the drug product specification, antimicrobial preservative effectiveness should
be demonstrated during development. The lowest specified concentration of
antimicrobial preservative should be demonstrated to be effective in
controlling microorganisms by using an antimicrobial preservative effectiveness
test. The concentration used should be justified in terms of efficacy and
safety, such that the minimum concentration of preservative that gives the
required level of efficacy throughout the intended shelf life of the product is
used. Where relevant, microbial challenge testing under testing conditions
that, as far as possible, simulate patient use should be performed during
development and documented in this section.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;F.
Compatibility&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The
compatibility of the drug product with reconstitution diluents (e.g.,
precipitation, stability) should be addressed to provide appropriate and
supportive information for the labelling. This information should cover the
recommended in-use shelf life, at the recommended storage temperature and at
the likely extremes of concentration. Similarly, admixture or dilution of
products prior to administration (e.g., product added to large volume infusion
containers) might need to be addressed.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;color: #0070c0; font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;Reference: ICH Q8 R2 Guidelines&lt;/span&gt;&lt;/i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;/div&gt;
&lt;br /&gt;&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/4810993433298523419/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/pharmaceutical-development-as-per-ich-guideline.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/4810993433298523419'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/4810993433298523419'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/pharmaceutical-development-as-per-ich-guideline.html' title='Pharmaceutical Development As Per ICH Guidelines'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_Un-mdgLOIlmm-m6buey_0Fo5GEJgGw_7F8HH4LXeLX_DimcNbTX89SR-yILhJx_NAjaszYWBrTO5L8Fo0a5pPmV85uxQbMqu06Ogeu1oRuOopdlFhjJxlqmWW2Qj01-PLhcF8Sq5z_AL/s72-c/Pharmaceutical+Development+As+Per+ICH+Guidelines.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-2067920926175473173</id><published>2020-05-24T07:21:00.000+05:30</published><updated>2020-05-24T07:31:31.431+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="Regulatory Agencies"/><title type='text'>Post-Notice of Compliance (NOC) Changes</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;Introduction:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;Following are the reasons for Post NOC changes:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;To
improve the quality of the drug. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;To
improve the efficiency of the manufacturing process. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;To
solve marketing issues. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;Changes
in the labeling of the drug for “warning” or managing the “risk factors” or
limiting the “targeted population” or limiting the “dosage”.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2020/05/post-notice-of-compliance-noc-changes.html&quot;&gt;&lt;img alt=&quot;Post-Notice of Compliance (NOC) Changes&quot; border=&quot;0&quot; data-original-height=&quot;194&quot; data-original-width=&quot;259&quot; height=&quot;239&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhKsm8dA9zRpnRjuSi_esf2eaofKRmvObpEkC4rObFbnYEpkihczhsx5d4jWVvxmN60h-BBXt8VNc9WeQne_L1AQnE6h2ibHjTOH651qlffUPE1-n-C8M_8GaiyztabA2tG-oYKUdbGAjHx/s320/Post-Notice+of+Compliance+%2528NOC%2529+Changes.jpg&quot; title=&quot;Post-Notice of Compliance (NOC) Changes&quot; width=&quot;320&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;color: #c45911; font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-themecolor: accent2; mso-themeshade: 191;&quot;&gt;These drugs may
include pharmaceuticals, biologics, and radiopharmaceuticals for human use and
pharmaceutical, radiopharmaceutical and certain biotechnological products for
veterinary use.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;Health Canada recognizes that:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin: 0in 0in 0.0001pt 38.3pt; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; mso-ansi-language: EN-US; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;any change to a drug may impact the safety, efficacy
and quality of that drug and;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: normal; margin: 0in 0in 0.0001pt 38.3pt; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; mso-ansi-language: EN-US; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;any change to the information associated with the drug
(for example [e.g.], labeling) may impact the safe and effective use of that
drug.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;To manage the safety and risks of the public in using
the drugs and foods, there are certain rules and regulations administered by
“Health Canada”.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;One important area of these regulations are
administrative rules managing the “Post Notice of Compliance” (Post NOC) related
to a drug.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;i&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;Post NOC provides sponsors with recommendations on the
data required to enable Health Canada to make an accurate determination of the
impact of a change on the safety, efficacy and quality of the new drug.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;Level
of changes to a drug and subsequent obligations of the sponsor are as
followings Levels:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; mso-ansi-language: EN-US; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;&quot;&gt;ü&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;Supplements.
(Data should be submitted to Health Canada for review prior to implementation.)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; mso-ansi-language: EN-US; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;&quot;&gt;ü&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;Notifiable
Changes. (Data should be submitted to Health Canada for review prior to
implementation.)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; mso-ansi-language: EN-US; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;&quot;&gt;ü&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;Annual
Notifications. (Data should not be submitted but should be available to health
Canada upon request)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt; text-indent: -0.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; mso-ansi-language: EN-US; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;&quot;&gt;ü&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;Record
of Changes. (Data should be retained by sponsor)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;Reporting Categories:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;Level I – Supplements:&lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;These changes to a new drug are “significantly
different” as it relates to the matters specified in C.08.003 (2) of the Food
and Drug Regulations and have the potential to impact the safety, efficacy,
quality and/or effective use of the drug.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;The changes included in this reporting category shall
be filed, along with the recommended supporting data, to Health Canada as a
Supplemental New Drug Submission (SNDS) or Supplemental Abbreviated New Drug
Submission (SANDS).&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span style=&quot;color: red; font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The change may not be implemented by the sponsor until a NOC has
been issued.&lt;/span&gt;&lt;/div&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;Level II - Notifiable Changes:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;These changes to a new drug have the potential to
impact the safety, efficacy, quality and/or effective use of the drug but do
not require the issuance of a NOC.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;(NOTE: All Level II - Notifiable Changes (Quality)
referred to in this document are not applicable to Human Pharmaceuticals)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;The changes included in this reporting category should
be filed, along with the recommended supporting data, to Health Canada as a
Notifiable Change.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span style=&quot;color: red; font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;All Level II changes should not be implemented by the sponsor until
a No Objection Letter (NOL) has been issued!&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;Level III - Annual Notifications:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;These changes to a new drug have minimal potential to
impact the safety, efficacy, quality, and/or effective use of the drug. The
changes included in this reporting category may be implemented by the sponsor
without the prior review by Health Canada of the data supporting such a change.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;These changes should be annotated in the affected
documents when filing the next submission to Health Canada to indicate those
Level III changes that have been implemented.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span style=&quot;color: red; font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The recommended supporting data should not be submitted but should
be available to Health Canada within thirty (30) calendar days if requested at
any time!&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;Level
IV - Record of Changes (Quality only):&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;These changes to a new drug are not Level I, Level II
or Level III and are not expected to impact the safety, efficacy, quality
and/or effective use of the drug. The changes included in this reporting the category may be implemented by the sponsor without prior review by Health
Canada.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt;&quot;&gt;
&lt;span style=&quot;color: red; font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;The changes should be retained as part of the drug product’s record
by either the sponsor or the manufacturer and comply with Good Manufacturing
Practices (GMP) requirements of Division 2 of the Food and Drug Regulations!&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;color: red; font-family: &amp;quot;arial&amp;quot; , sans-serif; mso-ansi-language: EN-US;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: red;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 0.0001pt; text-align: left;&quot;&gt;
&lt;span style=&quot;color: red;&quot;&gt;Source:&amp;nbsp;&lt;/span&gt;&lt;a href=&quot;https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/post-notice-compliance-changes/framework-document.html&quot; style=&quot;text-align: left;&quot;&gt;https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/post-notice-compliance-changes/framework-document.html&lt;/a&gt;&lt;/div&gt;
&lt;br /&gt;&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/2067920926175473173/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/post-notice-of-compliance-noc-changes.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/2067920926175473173'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/2067920926175473173'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/post-notice-of-compliance-noc-changes.html' title='Post-Notice of Compliance (NOC) Changes'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhKsm8dA9zRpnRjuSi_esf2eaofKRmvObpEkC4rObFbnYEpkihczhsx5d4jWVvxmN60h-BBXt8VNc9WeQne_L1AQnE6h2ibHjTOH651qlffUPE1-n-C8M_8GaiyztabA2tG-oYKUdbGAjHx/s72-c/Post-Notice+of+Compliance+%2528NOC%2529+Changes.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-4202002072374924877</id><published>2020-05-19T07:42:00.001+05:30</published><updated>2020-05-24T07:35:43.835+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="FDA"/><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="Regulatory Agencies"/><title type='text'>Guidance for changes to approved NDA or ANDA</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;FDA has published guidance to provide recommendations
to holders of new drug applications (NDAs) and abbreviated new drug
applications (ANDAs) who intend to make post-approval changes.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2020/05/Guidance-changes-approved-NDA-or-ANDA.html&quot;&gt;&lt;img alt=&quot;Guidance for changes to approved NDA or ANDA&quot; border=&quot;0&quot; data-original-height=&quot;163&quot; data-original-width=&quot;300&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhraQHCPun8qVZnH7LAsHmknIQ8ie9Gi7y9ZlT7rYasFg7TvLm4RJ1UttHwnSk6P6-O85TCYpB9HeWSav4uxqFc33JMsD2WwkvMuyXOwSAvFgIeRarvCRgJsrFCIpIOneepmcx9ApovA-DI/s1600/Guidance+for+changes+to+approved+NDA+or+ANDA.jpg&quot; title=&quot;Guidance for changes to approved NDA or ANDA&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Reporting Categories:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;There are &lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;four reporting categories which are
distinguished in the following paragraphs:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;A.&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;!--[endif]--&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Major Change: &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;It
&lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;is a
change that has a substantial potential to have an adverse effect on the
identity, strength, quality, purity, or potency of a drug product as these
factors may relate to the safety or effectiveness of the drug product.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;It requires the submission of a supplement and
approval by FDA prior to the distribution of the drug product made using the
change. (Prior Approval Supplement)&lt;/span&gt;&lt;br /&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;B.&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;!--[endif]--&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Moderate Change (CBE 30):&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;It is a change that has a moderate potential to
have an adverse effect on the identity, strength, quality, purity, or potency
of the drug product as these factors may relate to the safety or effectiveness
of the drug product.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;It requires the submission of a supplement to
FDA at least 30 days before the distribution of the drug product made using the
change. It is called Supplement - Changes Being Effected in 30 Days (CBE 30)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;C.&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;!--[endif]--&gt;&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Moderate Change (CBE 0):&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;It is a change that has a moderate potential to
have an adverse effect on the identity, strength, quality, purity, or potency
of the drug product as these factors may relate to the safety or effectiveness
of the drug product.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;It requires the submission of a supplement to
FDA at the time of distribution of the drug product made using the change. It
is called Supplement - Changes Being Effected (CBE 0)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;br /&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;color: red; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;If FDA disapproves CBE 30 or CBE 0 Supplement, FDA may order the
manufacturer to cease distribution of drug products made using the disapproved
changes.&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;D.&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;!--[endif]--&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Minor Change: &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;It is a change that has minimal potential to
have an adverse effect on the identity, strength, quality, purity, or potency
of the drug product as these factors may relate to the safety or effectiveness
of the drug product.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;The applicant has to describe minor changes in
its next Annual Report.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;General Requirements:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Other
than for editorial changes in previously submitted information, an applicant
must notify FDA about each change.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;A
supplement or annual report must include a list of all changes contained in the
supplement or annual report.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;The
applicant must describe each change fully in the supplement or annual report&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Assessing
the Effect of Manufacturing Changes&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l2 level1 lfo2; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;i&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;1.&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;!--[endif]--&gt;&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Assessment of the
Effects of the Change: &lt;/span&gt;&lt;/i&gt;&lt;i&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;This assessment is done either by &lt;i&gt;Conformance
to Specifications&lt;/i&gt; or &lt;i&gt;Additional Testing&lt;o:p&gt;&lt;/o:p&gt;&lt;/i&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l2 level1 lfo2; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;2.&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Equivalence&lt;/span&gt;&lt;/i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;:&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;An applicant should usually assess the extent
to which the manufacturing change has affected the SISPQ of the drug product. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l2 level1 lfo2; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;i style=&quot;mso-bidi-font-style: normal;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;3.&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;!--[endif]--&gt;&lt;i style=&quot;mso-bidi-font-style: normal;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Adverse Effect:&lt;/span&gt;&lt;/i&gt;&lt;i style=&quot;mso-bidi-font-style: normal;&quot;&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Some manufacturing changes have an adverse
effect on the SISPQ of the drug product.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Applicants should consult with the appropriate
CDER chemistry or microbiology review staff if there are any questions on
whether a change in a characteristic would be viewed by CDER as adversely
affecting the SISPQ of the drug product.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto;&quot;&gt;
&lt;br /&gt;
&lt;table border=&quot;1&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;MsoTableGrid&quot; style=&quot;border-collapse: collapse; border: none; margin-left: -20.75pt; mso-border-alt: solid windowtext .5pt; mso-padding-alt: 0in 5.4pt 0in 5.4pt; mso-yfti-tbllook: 1184; width: 651px;&quot;&gt;
 &lt;tbody&gt;
&lt;tr&gt;
  &lt;td style=&quot;border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.85pt;&quot; valign=&quot;top&quot; width=&quot;116&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin: 0in; mso-add-space: auto;&quot;&gt;
&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Changes&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 137.0pt;&quot; valign=&quot;top&quot; width=&quot;183&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin: 0in; mso-add-space: auto;&quot;&gt;
&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Major&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 129.65pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin: 0in; mso-add-space: auto;&quot;&gt;
&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Moderate&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-left: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 135.0pt;&quot; valign=&quot;top&quot; width=&quot;180&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin: 0in; mso-add-space: auto;&quot;&gt;
&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Minor&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr&gt;
  &lt;td style=&quot;border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.85pt;&quot; valign=&quot;top&quot; width=&quot;116&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin: 0in; mso-add-space: auto;&quot;&gt;
&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Manufacturing
  Sites&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 137.0pt;&quot; valign=&quot;top&quot; width=&quot;183&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A move to a different
  manufacturing site that has never been inspected by FDA.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Move to site that &lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;does not have a satisfactory CGMP inspection for the type
  of operation being moved.&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Transfer of the
  manufacture of an aseptically processed sterile drug substance that does not
  manufacture similar approved drug products. &lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Transfer of the
  manufacture of a finished drug product sterilized by terminal processes to a
  newly constructed facility at a different manufacturing site&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 129.65pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;
  &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Change in sites that is not provided in this guidance.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;
  &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A move to a different manufacturing site for the manufacture or processing of the final intermediate.&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 135.0pt;&quot; valign=&quot;top&quot; width=&quot;180&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;
  &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A move to a different manufacturing site for secondary
  packaging&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;
  &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A move to a different manufacturing site for labelling&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;
  &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A move to a different manufacturing site for the ink
  imprinting of solid oral dosage form drug products.&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr&gt;
  &lt;td style=&quot;border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.85pt;&quot; valign=&quot;top&quot; width=&quot;116&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin: 0in; mso-add-space: auto;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Manufacturing Process&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 137.0pt;&quot; valign=&quot;top&quot; width=&quot;183&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Changes that may
  affect the controlled release, metering or other characteristics of the dose
  delivered to the patient&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Changes that may
  affect drug product sterility assurance&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Changes in the
  sterilization method&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Changes in the sterilizer
  load configurations that are outside the range of previously validated loads.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Changes in materials
  or pore size rating of filters used in aseptic processing.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 129.65pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;
  &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;For drug products, any change in the process, process
  parameters, and/or equipment except as otherwise provided for in this
  guidance&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;
  &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Changes in dry heat depyrogenation processes for glass
  container systems&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;
  &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Changes to filtration parameters for aseptic processing&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;
  &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A change in methods or controls that provides increased
  assurance about SISPQ of the drug product.&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 135.0pt;&quot; valign=&quot;top&quot; width=&quot;180&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A minor change in an
  existing code imprint for a dosage form&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Addition or deletion
  of a code imprint by embossing, debossing, or engraving on a solid dosage
  form drug product&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A change in the order
  of addition of ingredients for solution dosage forms or solutions used in
  unit operations&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr&gt;
  &lt;td style=&quot;border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.85pt;&quot; valign=&quot;top&quot; width=&quot;116&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin: 0in; mso-add-space: auto;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Specifications&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 137.0pt;&quot; valign=&quot;top&quot; width=&quot;183&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Relaxing an
  acceptance criterion &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Deleting any part of
  a specification&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Establishing a new
  regulatory analytical procedure including designation of an alternative
  analytical procedure as a regulatory procedure.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 129.65pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Any change in a regulatory
  analytical procedure other than those identified as major changes&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Relaxing an
  acceptance criterion or deleting a test for raw materials used in drug
  substance manufacturing&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Relaxing an
  acceptance criterion or deleting a test to comply with an official compendium&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 135.0pt;&quot; valign=&quot;top&quot; width=&quot;180&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Tightening of
  acceptance criteria&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;addition or revision
  of an alternative analytical procedure that provides the same or increased
  assurance about SISPQ of the drug product.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr&gt;
  &lt;td style=&quot;border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.85pt;&quot; valign=&quot;top&quot; width=&quot;116&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin: 0in; mso-add-space: auto;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Container Closure System&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 137.0pt;&quot; valign=&quot;top&quot; width=&quot;183&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;a change from an ink
  and/or adhesive used on the permeable or semipermeable packaging component to
  an ink or adhesive&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A change in the
  primary packaging components, when the primary packaging components control
  the dose delivered to the patient&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A change to a
  prefilled syringe dosage form from another container system.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A change from a
  single unit dose container to a multiple-dose container system.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 129.65pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Changes in the size
  or shape of a container for a sterile drug substance&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A change in the
  number of units (e.g., tablets, capsules) or labeled amount (e.g., grams, milliliters)
  of a nonsterile drug product in a unit-of-use container&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A change in or
  addition or deletion of a desiccant.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 135.0pt;&quot; valign=&quot;top&quot; width=&quot;180&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A change in the size
  and/or shape of a container for a nonsterile solid dosage form&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;A change in the
  number of units (e.g., tablets, capsules) or labeled amount (e.g., grams) of
  nonsterile solid dosage form in a multiple-unit container&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;tr&gt;
  &lt;td style=&quot;border-top: none; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 86.85pt;&quot; valign=&quot;top&quot; width=&quot;116&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin: 0in; mso-add-space: auto;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Labeling&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 137.0pt;&quot; valign=&quot;top&quot; width=&quot;183&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Changes based on
  postmarketing study results&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Change in, or
  addition of, pharmacoeconomic claims based on clinical studies&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Changes based on data
  from preclinical studies.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.5pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Claims of superiority
  to another drug product.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 129.65pt;&quot; valign=&quot;top&quot; width=&quot;173&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Addition of an
  adverse event due to information reported to the applicant or Agency&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Addition of a
  precaution arising out of a postmarketing study.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 8.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -10.0pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Clarification of the
  administration statement to ensure proper administration of the drug product.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
  &lt;td style=&quot;border-bottom: solid windowtext 1.0pt; border-left: none; border-right: solid windowtext 1.0pt; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; width: 135.0pt;&quot; valign=&quot;top&quot; width=&quot;180&quot;&gt;&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Editorial changes,
  such as adding a distributor&#39;s name.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Foreign language
  versions of the labeling if no change is made to the content of the approved
  labeling and the certified translation is included.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 5.0pt; margin-right: 0in; margin-top: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-indent: -8.5pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;symbol&amp;quot;; font-size: 10.5pt;&quot;&gt;·&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 10.5pt;&quot;&gt;Labeling changes made
  to comply with an official compendium.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;
 &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt; line-height: 107%;&quot;&gt;Source: &lt;/span&gt;&lt;a href=&quot;https://www.fda.gov/media/71846/download&quot;&gt;https://www.fda.gov/media/71846/download&lt;/a&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt; line-height: 107%;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;br /&gt;&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/4202002072374924877/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/Guidance-changes-approved-NDA-or-ANDA.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/4202002072374924877'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/4202002072374924877'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/Guidance-changes-approved-NDA-or-ANDA.html' title='Guidance for changes to approved NDA or ANDA'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhraQHCPun8qVZnH7LAsHmknIQ8ie9Gi7y9ZlT7rYasFg7TvLm4RJ1UttHwnSk6P6-O85TCYpB9HeWSav4uxqFc33JMsD2WwkvMuyXOwSAvFgIeRarvCRgJsrFCIpIOneepmcx9ApovA-DI/s72-c/Guidance+for+changes+to+approved+NDA+or+ANDA.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-7180585650896558518</id><published>2020-05-16T17:15:00.000+05:30</published><updated>2020-05-24T07:39:47.048+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="FDA"/><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="Regulatory Agencies"/><title type='text'>Practical Tips for A Successful Pre-Approval Inspection (PAI) Outcome</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;div dir=&quot;ltr&quot; id=&quot;docs-internal-guid-3c521ade-7fff-2029-9d8c-116367109459&quot; style=&quot;line-height: 1.38; margin-bottom: 0pt; margin-top: 0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;
&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Once an application is submitted, the firms and
facilities mentioned are considered by FDA to be ready for inspection.&amp;nbsp;&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;i&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;The inspection team will determine if:&lt;/span&gt;&lt;/i&gt;&lt;i&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• the facility is prepared for commercial
manufacturing&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• the data submitted is according to site records&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• the data submitted is complete and accurate&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;
&lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2020/05/practical-tips-for-successful-pre.html&quot;&gt;&lt;img alt=&quot;Practical Tips for A Successful Pre-Approval Inspection (PAI) Outcome&quot; border=&quot;0&quot; data-original-height=&quot;198&quot; data-original-width=&quot;256&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg3WrFsM4eXAhFcPU-xwUPyH5YqM3BD5-SyR54g-hUZe0Cz4L7hnL0vwvV-czoXWJdkYbv5QT-vDXlhKizxYOXsw7wenUixPMR26REww0BtrS_re1_lbGhBCK0EKJsCZSsjR3qapWMqliTq/s1600/Practical+Tips+for+A+Successful+Pre-Approval+Inspection+%2528PAI%2529+Outcome.jpg&quot; title=&quot;Practical Tips for A Successful Pre-Approval Inspection (PAI) Outcome&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Readiness for Commercial Manufacture&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;i&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;The investigative team will determine whether your the firm contains a quality system that&#39;s designed to realize sufficient control
over the ability and commercial manufacturing operations.&lt;/span&gt;&lt;/i&gt;&lt;i&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Evaluate overall CGMP compliance because it
relates to the applying product&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Evaluate the particular PAI product and process&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;- is that the facility adequate/qualified-building;
equipment; water systems?&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;&amp;nbsp;&amp;nbsp;- Will review the development Report.&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Will review batch records for submission batches
(pivotal, qualification and/or bio batches)&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• specialize in change control, deviations and
trends regarding the event process to see that there&#39;s adequate evaluation&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Will evaluate sampling plans; testing of
components and products&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• High specialise in your supplier qualification
program&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Evaluate facility and equipment procedures with a
spotlight on contamination controls&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Specialise in laboratory system (SOPs; Personnel;
Training) and stability data&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;color: black; font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;• Evaluate test methods (validated?) and impurity
profile&lt;/span&gt;&lt;/div&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;
&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Conformance to Application&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;The investigators will verify that the formulation,
manufacturing and/or processing methods, and analytical methods are according
to descriptions contained within the CMC section of the application.&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;As a part of the inspection, they&#39;ll audit records,
equipment, procedures, and also the batch records submitted within the
application and furthermore inspect the manufacturing equipment and facility to
assure:&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;i&gt;&lt;u&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;That the proposed manufacturing
process is the same process that was used for the manufacturing of the
bio/stability batches (and other pivotal clinical batches).&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;i&gt;&lt;u&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Investigators will verify the following:&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Observe manufacturing operations and equipment to
assure they&#39;re according to those described within the application.&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Review on-site analytical methods to assure
they&#39;re according to those filed within the application&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Will assure that stability samples are stored
under the conditions described within the stability protocol filed with the application.
&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Investigators will compare stability lots and
testing conditions at the positioning versus what&#39;s listed within the
application. Investigators will visit stability chambers to verify:&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Correct packaging configuration&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Correct orientation&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Audit recording charts during the period&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Alarm logs&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Correct temp and humidity conditions&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Data Integrity&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;The investigators will audit the data&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;br /&gt;
&lt;i&gt;&lt;span style=&quot;color: black;&quot;&gt;Does the information have factual integrity?&lt;/span&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/i&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Data is accurately submitted within the
application&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Chromatogram directly calculates to summary&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;i&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Does the information have contextual integrity?&lt;/span&gt;&lt;/i&gt;&lt;i&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Data is supported by additional information
observed at the facility. &lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Missing records&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Unexplained losses of inventory of components&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Investigators review data used to generate
results&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Control/security of data&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Audit for authenticity and accuracy&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;br /&gt;
&lt;span style=&quot;color: black;&quot;&gt;• Review data for bio-batch and stability batch(es),
including laboratory testing and manufacturing&lt;/span&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Inventory records/equipment logs&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Passing data submitted rather than failing data&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Improper investigation of OOS results which were
then not submitted&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;• Exclusion of specific lots from the steadiness
program to avoid submitting failing results&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;i&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;“Companies must provide truthful and accurate&amp;nbsp;information
in their marketing applications…. The American public expects and deserves no
less.”&lt;/span&gt;&lt;/i&gt;&lt;i&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;br style=&quot;mso-special-character: line-break;&quot; /&gt;
&lt;!--[if !supportLineBreakNewLine]--&gt;&lt;br style=&quot;mso-special-character: line-break;&quot; /&gt;
&lt;!--[endif]--&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Product Specific findings and deficiencies that
ought to lead to a part recommendation to &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;color: red; font-size: 12.0pt;&quot;&gt;withhold approval&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: 12.0pt; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;br style=&quot;mso-special-character: line-break;&quot; /&gt;
&lt;!--[if !supportLineBreakNewLine]--&gt;&lt;br style=&quot;mso-special-character: line-break;&quot; /&gt;
&lt;!--[endif]--&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-size: 7pt; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Significant data integrity problems including
misrepresented data or other conditions associated with the submission batch.&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-size: 7pt; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Serious CGMP concerns with the manufacture of a bio-batch
or demonstration batch, like a change to formulation or processing which will
cause the FDA to question the integrity of the bioequivalence study.&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-size: 7pt; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Significant differences between the method used for
pivotal clinical batches and also the NDA submission batch.&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-size: 7pt; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Lack of complete manufacturing and control
instructions within the master production record or lack of knowledge to
support those instructions.&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-size: 7pt; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Lack of capacity to manufacture the drug product or
the API (if the firm isn&#39;t ready for an inspection, the district should request
a letter from the establishment).&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-size: 7pt; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Failure to fulfil application commitments.&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-size: 7pt; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Full scale process validation studies were
attempted before the PAI, demonstrate that the method isn&#39;t in restraint and
establishment isn&#39;t making appropriate changes.&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-size: 7pt; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;For products that full-scale summary information is
provided within the application, establishment has not demonstrated that the
merchandise is reliably manufactured at commercial scale and meet its critical
quality attributes.&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-size: 7pt; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Incomplete or unsuccessful method validation or
verification.&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-size: 7pt; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Records for pivotal clinical or submission batches
don&#39;t clearly identify equipment or processing parameters used.&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-size: 7pt; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Significant failures associated with the steadiness
study that raise questions about the steadiness of the merchandise or API.&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-size: 7pt; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;color: black; font-size: 12.0pt;&quot;&gt;Failure to report adverse findings or failing test
data without appropriate justification&lt;/span&gt;&lt;span style=&quot;font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt; line-height: 107%;&quot;&gt;To ensure a successful
PAI&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt; line-height: 107%;&quot;&gt;Have a proactive
compliance approach:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt; line-height: 107%;&quot;&gt;• Firm is attentive to
significant issues before inspection; CAPAs in place; if needed&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt; line-height: 107%;&quot;&gt;• Senior management is
attentive to compliance / inspection issues at site so there are not any
surprises during the inspection.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt; line-height: 107%;&quot;&gt;• Sponsor conducts due
diligence before they name contractors/suppliers in applications and prepares
all sites for PAIs.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt; line-height: 107%;&quot;&gt;• Quality and Operations
work together to analyse deviations/issues…Responsible person for issues
identified and accountable.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt; line-height: 107%;&quot;&gt;• Quality and Operations
work together to best present significant issues during inspections (identify
material Experts).&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt; line-height: 107%;&quot;&gt;• Have a development
report that compiles documentation that represents a radical understanding of
the appliance product and process.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt; line-height: 107%;&quot;&gt;• the event report
adequately is the idea for justification of the method to support the filing&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif; font-size: 12.0pt; line-height: 107%;&quot;&gt;• Communicate product and
process risks to manufacturing sites and have them reflective within the
performance measurements that are collected and monitored during manufacturing
to assist prevent problems after launch.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , &amp;quot;helvetica&amp;quot; , sans-serif;&quot;&gt;&lt;span style=&quot;font-size: 12.0pt; line-height: 107%;&quot;&gt;Source: &lt;/span&gt;&lt;a href=&quot;https://www.fda.gov/media/94064/download&quot;&gt;&lt;span style=&quot;background: white; color: #0056b3;&quot;&gt;https://www.fda.gov/media/94064/download&lt;/span&gt;&lt;/a&gt;&lt;span style=&quot;font-size: 12.0pt; line-height: 107%;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/7180585650896558518/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/practical-tips-for-successful-pre.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/7180585650896558518'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/7180585650896558518'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/practical-tips-for-successful-pre.html' title='Practical Tips for A Successful Pre-Approval Inspection (PAI) Outcome'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg3WrFsM4eXAhFcPU-xwUPyH5YqM3BD5-SyR54g-hUZe0Cz4L7hnL0vwvV-czoXWJdkYbv5QT-vDXlhKizxYOXsw7wenUixPMR26REww0BtrS_re1_lbGhBCK0EKJsCZSsjR3qapWMqliTq/s72-c/Practical+Tips+for+A+Successful+Pre-Approval+Inspection+%2528PAI%2529+Outcome.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-6482641248625618227</id><published>2020-05-15T20:27:00.000+05:30</published><updated>2020-05-24T07:42:19.469+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="FDA"/><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="Regulatory Agencies"/><title type='text'>FDA’s Pre-Approval Inspection (PAI)</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;div dir=&quot;ltr&quot; id=&quot;docs-internal-guid-ea5008b7-7fff-b3b3-47f5-f874cbaae1e6&quot; style=&quot;line-height: 1.38; margin-bottom: 0pt; margin-top: 0pt;&quot;&gt;
&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Facility Evaluation by FDA&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Before
approval, FDA evaluates the firm or facility by on-site inspections and/or by
establishment file review when the firm is called within the Chemistry, Manufacturing,
and Controls (CMC) section of a New Drug Application (NDA), Abbreviated New
Drug Application (ANDA) or Biologic License Application (BLA)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2020/05/fdas-pre-approval-inspection-pai.html&quot;&gt;&lt;img alt=&quot;FDA’s Pre-Approval Inspection (PAI)&quot; border=&quot;0&quot; data-original-height=&quot;401&quot; data-original-width=&quot;600&quot; height=&quot;213&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgscErDHuPYnHkxz1z3JuvLzwT_Ht998niIt3iS18-qeQMz8XHpM1uWJyoJXPwkS2_uOQ4JJ_aumTYhCIe3xVXd7_0bEP0VZCNgVEuFeJXpm8MFMSCUX-TQ2eQfveKLwWQJbfNBHMnN0ZCc/s320/FDA%25E2%2580%2599s+Pre-Approval+Inspection+%2528PAI%2529.png&quot; title=&quot;FDA’s Pre-Approval Inspection (PAI)&quot; width=&quot;320&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Facility
evaluations are conducted for:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;–
Finished dosage manufacturers&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;–
API manufacturers&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;–
Finished dosage and API testing sites&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;–
Primary packaging and labeling sites&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;–
For animal-derived APIs, the power that performs the crude extraction&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;FDA
generally doesn&#39;t evaluate the subsequent sites for a pre-approval inspection:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;u&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Intermediate
manufacturers&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/u&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
On a case-by-case basis; evaluated on condition that the intermediate is taken
into account critical to the standard of the drug product.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;u&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Exhibit
batch manufacturers (if not proposed commercial site)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/u&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Note: the positioning may be added on a for-cause basis if the review
identifies concerns&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;u&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Component
manufacturers&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/u&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Includes syringes, glass vials, or rubber-stoppers manufacturers and
component-only sterilization sites&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
OPF/DIA generally doesn&#39;t evaluate these sites unless the for-cause basis&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
it&#39;s the drug product manufacturer’s responsibility to qualify their suppliers.&lt;/span&gt;&lt;br /&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;u&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Excipient
manufacturers&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/u&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
OPF/DIA generally doesn&#39;t evaluate these sites, unless it&#39;s a completely unique
excipient and/or the excipient &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;the
manufacturing process is taken into account a critical step within the overall
drug manufacturing process.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;u&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Secondary
packager/labeller&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/u&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
OPF/DIA generally doesn&#39;t evaluate these sites&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;*note
all the above sites are required to fulfil the statutory CGMPs per FD&amp;amp;C Act
and should be routinely inspected if registered as a drug manufacturer.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;When
does FDA perform PAIs?&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Use
risk-based Priority Inspection Criteria to create the choice supported the
subsequent risks:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•Facility
Risk&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•Product
Risk&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•Process
Risk&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Facility
Risk&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
CGMP issues relevant to application product&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Recent FARs relevant to application product&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Recent recalls relevant to application product&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Numerous applications filed without delay&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Product
Risk&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
New molecular entity&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
First application filed by the applicant &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
First ANDA filed for an approved drug&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
RLD has complaints, ADEs, stability issues&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Patient population or for a heavy condition&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Breakthrough therapy, shortage situation&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Process
Risk&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Narrow therapeutic range (95%-105%) &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Derived API is high risk (derived from animal tissues)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
PAT, NIR, QbD&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Development data is incomplete&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Batch records non-specific&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Complicated process&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Substantially different process than previously covered at the power.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;The
Pre-Approval Inspection team&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;If
an inspection is confirmed to be conducted, FDA will send a team of people to
conduct the pre-approval inspection. The team may include:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Investigators&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Other Specialists&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;–
Chemistry Expert&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;–
Microbiology Expert&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;–
Process/Facility Expert&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;–
Formulation Expert&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Scope
of PAI&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;A
pre-approval inspection (PAI) is performed to contribute to FDA’s assurance
that a producing establishment named during a drug application is capable of
producing a drug, which submitted data are accurate and complete.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;PAI
is product specific&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Limited or no commercial manufacturing &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
More specialise in development data &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
More emphasis on the authenticity of information and application commitments.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Process validation commonly not completed&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Trend toward more experts involved.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;PAI
Coverage: Objectives&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Objective
1: Readiness for Commercial Manufacturing &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Determine
whether the establishment(s) includes a quality system that&#39;s designed to
attain sufficient control over the power and commercial manufacturing
operations. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Objective
2: Conformance to Application&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Verify
that the formulation of product, processing methods and analytical (or
examination) methods are according to descriptions contained within the CMC
section of the application for the bio-batch (and other pivotal clinical
batches, when applicable), the proposed commercial-scale batch, and also the
API(s). &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Objective
3: Data Integrity Audit &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Audit
the information, hardcopy or electronic, to authenticate the data submitted
within the CMC section of the application. Verify that each one relevant data
(e.g., stability, bio-batch data) were submitted within the CMC section that product
reviewers can depend on the submitted data as complete and accurate.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;b&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;PAI
Outcomes&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;The
lead investigator will make a recommendation at the conclusion of the
inspection:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Recommend
Approval&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Depicts that the inspection has no significant issues&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Response to observations is vital&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Recommend
Withholding of Approval&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Investigators observed that the positioning isn&#39;t GMP compliant, the data in
CMC isn&#39;t according to site records, or information submitted isn&#39;t accurate
and complete.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;•
Response to observations is critical &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;i&gt;&lt;span style=&quot;color: #c55a11; font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;*CDER’s Office of
latest Drugs or Office of Generic Drugs makes the final word decision on whether
to approve or withhold approval of the applying or licensure&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Also
Read: &lt;i&gt;&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2020/05/practical-tips-for-successful-pre.html&quot;&gt;Practical
Tips for A Successful Pre-Approval Inspection (PAI) Outcome&lt;/a&gt;&lt;/i&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;times new roman&amp;quot; , serif; font-size: 12.0pt;&quot;&gt;Source:
&lt;/span&gt;&lt;a href=&quot;https://www.fda.gov/media/94064/download&quot;&gt;&lt;span style=&quot;background: white; color: #0056b3; font-family: &amp;quot;arial&amp;quot; , sans-serif;&quot;&gt;https://www.fda.gov/media/94064/download&lt;/span&gt;&lt;/a&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/6482641248625618227/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/fdas-pre-approval-inspection-pai.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/6482641248625618227'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/6482641248625618227'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/fdas-pre-approval-inspection-pai.html' title='FDA’s Pre-Approval Inspection (PAI)'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgscErDHuPYnHkxz1z3JuvLzwT_Ht998niIt3iS18-qeQMz8XHpM1uWJyoJXPwkS2_uOQ4JJ_aumTYhCIe3xVXd7_0bEP0VZCNgVEuFeJXpm8MFMSCUX-TQ2eQfveKLwWQJbfNBHMnN0ZCc/s72-c/FDA%25E2%2580%2599s+Pre-Approval+Inspection+%2528PAI%2529.png" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-5787945629182910645</id><published>2020-05-14T21:21:00.000+05:30</published><updated>2020-05-24T07:45:47.925+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="FDA"/><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="Regulatory Agencies"/><title type='text'>Basics of 4 types of FDA Inspections</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;div style=&quot;background-color: white; box-sizing: border-box; color: #212529; font-family: Georgia, serif; font-size: 16px; margin-bottom: 1rem;&quot;&gt;
&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;If you&#39;re a
manufacturer or a processor of FDA-regulated products, you&#39;ll expect a visit
from FDA. the aim of this visit is to verify compliance with all relevant
regulations — most ordinarily stated as an “FDA inspection.”&lt;span style=&quot;mso-spacerun: yes;&quot;&gt;&amp;nbsp; &lt;/span&gt;But not all inspections are created equal.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;br /&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://guidelinesup2date.blogspot.com/2020/05/basics-of-4-types-of-fda-inspections.html&quot;&gt;&lt;img alt=&quot;Basics of 4 types of FDA Inspections&quot; border=&quot;0&quot; data-original-height=&quot;165&quot; data-original-width=&quot;306&quot; height=&quot;215&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi4tsVNNRMwe4A3EbZOJq3UFQoQlYIXmg8Zt6em1UuHyF_Y-lFVbh5KUEvztxBAaJeCQdIg81l06t6GBxFEsKMLEgXUCWNaK8-_QC3GABmv_m6NTKN6_1tuazx46GjbA63hwFzxW0CVEnV0/s400/Basics+of+4+types+of+FDA+Inspections.jpg&quot; title=&quot;Basics of 4 types of FDA Inspections&quot; width=&quot;400&quot; /&gt;&lt;/a&gt;&lt;span id=&quot;goog_829300848&quot;&gt;&lt;/span&gt;&lt;a href=&quot;https://www.blogger.com/&quot;&gt;&lt;/a&gt;&lt;span id=&quot;goog_829300849&quot;&gt;&lt;/span&gt;&lt;/div&gt;
&lt;br /&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;FDA performs four kinds
of inspections at many various kinds of facilities, and your company’s response
should be tailored to the precise sort of event. Facilities that represent
FDA’s watchful eye include:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;ü&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Drug manufacturers &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;ü&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Device manufacturers&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;ü&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Blood banks&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;ü&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Food processing facilities&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;ü&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Dairy farms&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;ü&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Animal feed processors&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;ü&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Compounding pharmacies relevant to your FDA inspects&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;ü&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Facilities that conduct studies in people&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;ü&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Laboratories that conduct studies in animals (support FDA approval of
medical products)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; text-align: justify;&quot;&gt;
&lt;br /&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;FDA’s inspection
authority also extends to foreign manufacturing and processing sites for
FDA-regulated products sold within the US. Fall within these bounds, and you&#39;ll
expect an FDA inspection at your facility.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;The four differing
kinds of inspections conducted by FDA are pre-approval inspection, routine
inspection, compliance follow-up inspection, and “for cause” inspection.&lt;span style=&quot;mso-spacerun: yes;&quot;&gt;&amp;nbsp; &lt;/span&gt;Each is meant to assist protect the general
public from unsafe products, but the main target and expectations of every sort
of inspection are different.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpFirst&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l1 level1 lfo2; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;Ø&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Pre-Approval Inspections&lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt; are conducted
after an organization submits an application to FDA to market products for NDA
or ANDA. These inspections target verifying data included within the
application, and confirming that the firm is capable of producing said product.
At the end of inspection inspectors will recommend for or against FDA approval.&lt;/span&gt;&lt;br /&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l1 level1 lfo2; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;Ø&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Routine Inspections&lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt; are expected at every
2 years for Class II and Class III device manufacturers.&lt;span style=&quot;mso-spacerun: yes;&quot;&gt;&amp;nbsp; &lt;/span&gt;They follow a prescribed method referred to
as Quality System Inspection Technique (QSIT). If a heavy public health risk is
identified during a routine inspection, the inspection type may then switch to
a “for cause” inspection.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l1 level1 lfo2; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;Ø&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Compliance Follow-Up Inspections&lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;
assures actions taken by a facility in response to a previous audit that
resulted in significant 483 observations or a Warning Letter. This inspection is
conducted to verify the adequate correction of previous discrepancies, to
document continuing violations, or to support future regulatory action.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpMiddle&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoListParagraphCxSpLast&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; mso-add-space: auto; mso-list: l1 level1 lfo2; text-align: justify; text-indent: -.25in;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;wingdings&amp;quot;; font-size: 12.0pt;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;Ø&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;“For Cause” Inspections &lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;investigate a
particular problem that has been reported to FDA. The source of the report will
be the manufacturer (e.g., resultant of a recall, MDR), consumer/user
complaints, or perhaps a dissatisfied employee.&lt;span style=&quot;mso-spacerun: yes;&quot;&gt;&amp;nbsp;
&lt;/span&gt;A “for cause” inspection will target the definite issue, but can expand
to hide unrelated elements of the firm’s operations. This inspection usually is
initiated at the request of CDRH, ORA, or regional directive. These inspections
typically are more in-depth than routine audits, and that they might not follow
a QSIT approach.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: normal; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;Source: &lt;/span&gt;&lt;span style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;a href=&quot;https://www.meddeviceonline.com/doc/understanding-the-types-of-fda-inspection-0001&quot;&gt;&lt;span style=&quot;background: white; color: #0053b3;&quot;&gt;https://www.meddeviceonline.com/doc/understanding-the-types-of-fda-inspection-0001&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span lang=&quot;EN-US&quot; style=&quot;font-family: &amp;quot;arial&amp;quot; , sans-serif; font-size: 12.0pt;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;br /&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/5787945629182910645/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/basics-of-4-types-of-fda-inspections.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/5787945629182910645'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/5787945629182910645'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/basics-of-4-types-of-fda-inspections.html' title='Basics of 4 types of FDA Inspections'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi4tsVNNRMwe4A3EbZOJq3UFQoQlYIXmg8Zt6em1UuHyF_Y-lFVbh5KUEvztxBAaJeCQdIg81l06t6GBxFEsKMLEgXUCWNaK8-_QC3GABmv_m6NTKN6_1tuazx46GjbA63hwFzxW0CVEnV0/s72-c/Basics+of+4+types+of+FDA+Inspections.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-1074715399209881924</id><published>2020-05-13T07:46:00.001+05:30</published><updated>2020-05-13T07:49:04.500+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Covid-19"/><title type='text'>Indian companies working on Covid-19 vaccines</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
Six Indian companies are working on a vaccine for COVID-19, joining global efforts to find a quick preventive for the deadly infection spreading rapidly across the world, says a top Indian scientist.&lt;br /&gt;
“While Zydus Cadila is working on two vaccines, Serum Institute, Biological E, Bharat Biotech, Indian Immunologicals, and Mynvax are developing one vaccine each,” Gagandeep Kang, executive director of the Translational Health Science and Technology Institute, Faridabad, told&amp;nbsp;&lt;em&gt;Press Trust of India&lt;/em&gt;.&lt;br /&gt;
“Vaccine development is a lengthy process which takes years, with many challenges,” said E. Sreekumar, chief scientific officer at the Rajiv Gandhi Centre for Biotechnology in Kerala.&lt;br /&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;br /&gt;
&lt;span id=&quot;more-33&quot;&gt;&lt;/span&gt;&lt;br /&gt;
“Generally, vaccines take several months to pass different stages of testing, and then approvals also take time. For Covid-19, we don’t expect a vaccine this year,” Rakesh Mishra, director of CSIR-Centre for Cellular &amp;amp; Molecular Biology in Hyderabad, said.&lt;br /&gt;
&lt;h3&gt;
Phase-Wise Development&lt;/h3&gt;
Vaccine testing typically begins with animals in the lab before going on to different stages of human clinical trials. “The human testing phase is composed of many phases,” Sreekumar told&amp;nbsp;&lt;em&gt;PTI&lt;/em&gt;.&lt;br /&gt;
“Phase 1 trials are small-scale, usually involving few participants, to assess whether the vaccine is safe for humans. Phase 2 trials often involve several hundred subjects, and mainly evaluate the efficacy of the vaccine against the disease,” he said.&lt;br /&gt;
The final phase involves thousands of people to further assess the efficacy of the vaccine over a defined period of time, and can last several months, Sreekumar said.&lt;br /&gt;
Though Kang named six companies, the WHO has listed only Zydus Cadila and Serum Institute from India as among the global firms working on a Covid-19 vaccine.&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/1074715399209881924/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/indian-companies-working-on-covid-19.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/1074715399209881924'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/1074715399209881924'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2020/05/indian-companies-working-on-covid-19.html' title='Indian companies working on Covid-19 vaccines'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-5334907110707806839</id><published>2017-08-15T08:15:00.000+05:30</published><updated>2020-05-15T20:30:48.436+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Regulatory Agencies"/><title type='text'>Pharmaceutical Regulatory Agencies and Organizations around the World</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;b&gt;Major Regulatory Agencies around the World:&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;table border=&quot;1&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;background-color: white; border-collapse: collapse; border-spacing: 0px; box-sizing: border-box; color: #333333; font-family: Roboto, sans-serif; font-size: 13px; max-width: 100%; outline: none;&quot;&gt;&lt;tbody style=&quot;border-top: 1px solid rgb(204, 204, 204); box-sizing: border-box; outline: none;&quot;&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;&lt;span style=&quot;box-sizing: border-box; font-weight: 700; outline: none;&quot;&gt;Country&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;&lt;span style=&quot;box-sizing: border-box; font-weight: 700; outline: none;&quot;&gt;Name of&amp;nbsp; Regulatory Authority&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;USA&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;&amp;nbsp;Food and Drug Administration (FDA)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;UK&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Medicines and Healthcare Products Regulatory Agency (MHRA)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Australia&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;&amp;nbsp;Therapeutic Goods Administration (TGA)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;India&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;&amp;nbsp;Central Drug Standard Control Organization (CDSCO)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Canada&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;&amp;nbsp;Health Canada&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Europe&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;European Medicines Agency (EMEA)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Denmark&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Danish Medicines Agency&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Costa Rica&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Ministry of Health&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;New Zealand&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Medsafe - Medicines and Medical Devices Safety Authority&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Sweden&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Medical Products Agency (MPA)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Netherlands&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Medicines Evaluation Board&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Ireland&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Irish Medicines Board&lt;/span&gt;&lt;br /&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Italy&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;&amp;nbsp;Italian Pharmaceutical Agency&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Nigeria&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;&amp;nbsp;National Agency for Food and Drug Administration and Control (NAFDAC)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Ukraine&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;&amp;nbsp;Ministry of Health&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Singapore&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Centre for Pharmaceutical Administration Health Sciences Authority&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Hong Kong&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Department of Health: Pharmaceutical Services&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Paraguay&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Ministry of Health&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Sweden&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Medical Products Agency (MPA)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; height: 10px; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Thailand&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; height: 10px; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;&amp;nbsp;Ministry of Public Health&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; height: 22px; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;China&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; height: 22px; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;State Food and Drug Administration&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Germany&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Federal Institute for Drugs and&amp;nbsp; Medical Devices&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Malaysia&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;National Pharmaceutical Control Bureau,Ministry of Health&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; height: 19px; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Pakistan&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; height: 19px; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Drugs Control Organization, Ministry of Health&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;South Africa&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Medicines Control Council&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Sri Lanka&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;SPC,Ministry of Health&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Switzerland&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Swissmedic&amp;nbsp; , Swiss Agency for Therapeutic Products&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Uganda&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Uganda National Council for Science and Technology (UNCST)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;h3 class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; color: inherit; font-family: inherit; font-size: 24px; font-weight: 500; line-height: 1.1; margin-bottom: 10px; margin-top: 20px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Brazil&lt;/span&gt;&lt;/h3&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Agencia Nacional de Vigiloncia Sanitaria (ANVISA )&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 104px;&quot;&gt;&lt;h3 class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; color: inherit; font-family: inherit; font-size: 24px; font-weight: 500; line-height: 1.1; margin-bottom: 10px; margin-top: 20px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Japan&lt;/span&gt;&lt;/h3&gt;
&lt;/td&gt;&lt;td style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 567px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Ministry of Health, Labour &amp;amp; Welfare(MHLW)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td colspan=&quot;2&quot; style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 671px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;&lt;span style=&quot;box-sizing: border-box; font-weight: 700; outline: none;&quot;&gt;INTERNATIONAL ORGANIZATIONS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td colspan=&quot;2&quot; style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 671px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;World Health Organization (WHO)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td colspan=&quot;2&quot; style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 671px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;Pan American Health Organization (PAHO)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td colspan=&quot;2&quot; style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 671px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;World Trade Organization (WTO)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td colspan=&quot;2&quot; style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 671px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;International Conference on Harmonization (ICH)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style=&quot;box-sizing: border-box; outline: none;&quot;&gt;&lt;td colspan=&quot;2&quot; style=&quot;box-sizing: border-box; outline: none; padding: 10px; width: 671px;&quot;&gt;&lt;div class=&quot;rtejustify&quot; style=&quot;box-sizing: border-box; margin-bottom: 10px; outline: none; text-align: justify;&quot;&gt;
&lt;span style=&quot;box-sizing: border-box; font-family: &amp;quot;verdana&amp;quot; , &amp;quot;geneva&amp;quot; , sans-serif; outline: none;&quot;&gt;World Intellectual Property Organization (WIPO)&lt;/span&gt;&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
&lt;br /&gt;
&lt;br /&gt;
Ref:&lt;br /&gt;
&lt;a href=&quot;http://www.pharmatutor.org/articles/pharmaceutical-regulatory-agencies-and-organizations-around-world-scope-challenges-in-drug-development&quot;&gt;http://www.pharmatutor.org/articles/pharmaceutical-regulatory-agencies-and-organizations-around-world-scope-challenges-in-drug-development&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/5334907110707806839/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2017/08/pharmaceutical-regulatory-agencies-and.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/5334907110707806839'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/5334907110707806839'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2017/08/pharmaceutical-regulatory-agencies-and.html' title='Pharmaceutical Regulatory Agencies and Organizations around the World'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-2917201359248065376</id><published>2017-08-15T07:59:00.004+05:30</published><updated>2020-05-15T20:30:30.358+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="ICH Guidelines"/><title type='text'>ICH Guidelines- Multidisciplinary Guidelines</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;b&gt;ICH&amp;nbsp;Multidisciplinary&amp;nbsp;Guidelines:&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Revised ICH Multidisciplinary Guidelines are listed below:&lt;br /&gt;
&lt;div&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;M1 MedDRA Terminology&amp;nbsp;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
MedDRA Medical Dictionary for Regulatory Activities&lt;/div&gt;
&lt;div&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;M2 Electronic Standards&amp;nbsp;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
ESTRI Electronic Standards for the Transfer of Regulatory Information&lt;/div&gt;
&lt;div&gt;
&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;M3 Nonclinical Safety Studies&amp;nbsp;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
M3(R2) - Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals&amp;nbsp;&lt;/div&gt;
&lt;div&gt;
M3(R2) Q&amp;amp;As R - Questions &amp;amp; Answers: Guidance on Non-Clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization
for Pharmaceuticals&amp;nbsp;&lt;/div&gt;
&lt;div&gt;
&lt;br /&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;M4 Common Technical Document&amp;nbsp;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
CTD The Common Technical Document&lt;/div&gt;
&lt;div&gt;
&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;M5 Data Elements and Standards for Drug Dictionaries&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
M5 Data Elements and Standards for Drug Dictionaries&lt;/div&gt;
&lt;div&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;M6 Gene Therapy&amp;nbsp;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
M6 Virus and Gene Therapy Vector Shedding and Transmission&lt;/div&gt;
&lt;div&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;M7 Genotoxic Impurities&amp;nbsp;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
M7(R1) Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk&lt;/div&gt;
&lt;div&gt;
&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;M8 Electronic Common Technical Document (eCTD)&amp;nbsp;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
Electronic Common Technical Document (eCTD)&lt;/div&gt;
&lt;div&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;M9 Biopharmaceutics Classification System-based Biowaivers&amp;nbsp;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
M9 Biopharmaceutics Classification System-based Biowaivers&lt;/div&gt;
&lt;div&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;M10 Bioanalytical Method Validation&amp;nbsp;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div&gt;
M10 Bioanalytical Method Validation&lt;/div&gt;
&lt;div&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div&gt;
Ref:&lt;/div&gt;
&lt;div&gt;
&lt;a href=&quot;http://www.ich.org/products/guidelines/multidisciplinary/article/multidisciplinary-guidelines.html&quot; target=&quot;_blank&quot;&gt;ICH&amp;nbsp;Multidisciplinary&amp;nbsp;Guidelines&lt;/a&gt;&lt;/div&gt;
&lt;div&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/2917201359248065376/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2017/08/ich-guidelines-multidisciplinary.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/2917201359248065376'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/2917201359248065376'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2017/08/ich-guidelines-multidisciplinary.html' title='ICH Guidelines- Multidisciplinary Guidelines'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-2016164691252995657</id><published>2017-08-14T09:50:00.001+05:30</published><updated>2020-05-15T20:30:11.838+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="ICH Guidelines"/><title type='text'>ICH Guidelines- Efficacy Guidelines</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;b&gt;ICH Efficacy&amp;nbsp;Guidelines:&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Revised ICH Efficacy Guidelines are listed below:&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
&lt;b&gt;E1 Clinical Safety for Drugs used in Long-Term Treatment&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
E1 The Extent of Population Exposure to Assess Clinical Safety for Drugs Intended for Long-Term Treatment of Non-Life
Threatening Conditions&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E2A - E2F Pharmacovigilance&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting&lt;br /&gt;
E2B(R3) Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports&lt;br /&gt;
E2B(R3) IWG Implementation: Electronic Transmission of Individual Case Safety Reports&lt;br /&gt;
E2C(R2) Periodic Benefit-Risk Evaluation Report&lt;br /&gt;
E2C(R2) Q&amp;amp;As Questions &amp;amp; Answers: Periodic Benefit-Risk Evaluation Report&lt;br /&gt;
E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting
E2E Pharmacovigilance Planning&lt;br /&gt;
E2F Development Safety Update Report&lt;br /&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E3 Clinical Study Reports&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E3 Structure and Content of Clinical Study Reports&lt;br /&gt;
E3 Q&amp;amp;As R1 Questions &amp;amp; Answers: Structure and Content of Clinical Study Reports&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E4 Dose-Response Studies&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E4 Dose-Response Information to Support Drug Registration&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E5 Ethnic Factors&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E5(R1) Ethnic Factors in the Acceptability of Foreign Clinical Data&lt;br /&gt;
E5 Q&amp;amp;As (R1) Questions &amp;amp; Answers: Ethnic Factors in the Acceptability of Foreign Clinical Data&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
&lt;b&gt;E6 Good Clinical Practice&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E6(R2) Good Clinical Practice (GCP)&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E7 Clinical Trials in Geriatric Population&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E7 Studies in Support of Special Populations: Geriatrics&lt;br /&gt;
E7 Q&amp;amp;As Questions &amp;amp; Answers: Studies in Support of Special Populations : Geriatrics&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E8 General Considerations for Clinical Trials&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E8 General Considerations for Clinical Trials&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
&lt;b&gt;E9 Statistical Principles for Clinical Trials&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E9(R1) Addendum: Statistical Principles for Clinical Trials (copy 1)&lt;br /&gt;
E9 Statistical Principles for Clinical Trials&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E10 Choice of Control Group in Clinical Trials&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E10 Choice of Control Group and Related Issues in Clinical Trials&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E11 Clinical Trials in Pediatric Population&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E11 Clinical Investigation of Medicinal Products in the Pediatric Population&lt;br /&gt;
E11(R1) Addendum: Clinical Investigation of Medicinal Products in the Pediatric Population&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E12 Clinical Evaluation by Therapeutic Category&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E12 Principles for Clinical Evaluation of New Antihypertensive Drugs&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E14 Clinical Evaluation of QT&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E14 The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs&lt;br /&gt;
E14 Q&amp;amp;As (R3) Questions &amp;amp; Answers: The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic
Drugs&lt;br /&gt;
E14/S7B Discussion Group on Clinical and non-Clinical Evaluation of QT/QTc Interval Prolongation&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E15 Definitions in Pharmacogenetics / Pharmacogenomics&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E15 Definitions for Genomic Biomarkers, Pharmacogenomics, Pharmacogenetics, Genomic Data and Sample Coding Categories&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E16 Qualification of Genomic Biomarkers&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E16 Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure and Format of Qualification
Submissions&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E17 Multi-Regional Clinical Trials&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E17 General principle on planning/designing Multi-Regional Clinical Trials&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E18 Genomic Sampling&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E18 Genomic Sampling and Management of Genomic Data&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;E19 Safety Data Collection&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
E19 Optimisation of Safety Data Collection&lt;br /&gt;
&lt;br /&gt;
Ref:&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html&quot; target=&quot;_blank&quot;&gt;ICH Efficacy Guidelines&lt;/a&gt;&amp;nbsp;&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/2016164691252995657/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2017/08/ich-guidelines-efficacy-guidelines.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/2016164691252995657'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/2016164691252995657'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2017/08/ich-guidelines-efficacy-guidelines.html' title='ICH Guidelines- Efficacy Guidelines'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-3383815247836641410</id><published>2017-08-14T09:38:00.000+05:30</published><updated>2020-05-15T20:29:50.493+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="ICH Guidelines"/><title type='text'>ICH Guidelines- Safety Guidelines</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;b&gt;ICH Safety Guidelines:&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Revised ICH Safety Guidelines are listed below:&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;S1A - S1C Carcinogenicity Studies&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
S1 Rodent Carcinogenicity Studies for Human Pharmaceuticals&lt;br /&gt;
S1A Need for Carcinogenicity Studies of Pharmaceuticals&lt;br /&gt;
S1B Testing for Carcinogenicity of Pharmaceuticals&lt;br /&gt;
S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;S2 Genotoxicity Studies&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
S2(R1) Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use&lt;br /&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;S3A - S3B Toxicokinetics and Pharmacokinetics&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
S3A Note for Guidance on Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies
S3A Q&amp;amp;As Questions and Answers: Note for Guidance on Toxicokinetics: The Assessment of Systemic Exposure - Focus on Microsampling&lt;br /&gt;
S3B Pharmacokinetics: Guidance for Repeated Dose Tissue Distribution Studies&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;S4 Toxicity Testing&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
S4 Duration of Chronic Toxicity Testing in Animals (Rodent and Non Rodent Toxicity Testing)&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;S5 Reproductive Toxicology&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
S5(R2) Detection of Toxicity to Reproduction for Medicinal Products &amp;amp; Toxicity to Male Fertility S5(R3) Revision of S5 Guideline on Detection of Toxicity to Reproduction for Human Pharmaceuticals&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;S6 Biotechnological Products&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;S7A - S7B Pharmacology Studies&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
S7A Safety Pharmacology Studies for Human Pharmaceuticals&lt;br /&gt;
S7B The Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human
Pharmaceuticals&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;S8 Immunotoxicology Studies&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
S8 Immunotoxicity Studies for Human Pharmaceuticals&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;S9 Nonclinical Evaluation for Anticancer Pharmaceuticals&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
S9 Nonclinical Evaluation for Anticancer Pharmaceuticals&lt;br /&gt;
S9 Q&amp;amp;As Questions and Answers: Nonclinical Evaluation for Anticancer Pharmaceuticals&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;S10 Photosafety Evaluation&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
S10 Photosafety Evaluation of Pharmaceuticals&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
&lt;b&gt;S11 Nonclinical Safety Testing
Cross-cutting Topics&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;
S11 Nonclinical Safety Testing in Support of Development of Paediatric Medicines&lt;br /&gt;
&lt;br /&gt;
Ref:&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.ich.org/products/guidelines/safety/article/safety-guidelines.html&quot; target=&quot;_blank&quot;&gt;ICH Safety Guidelines&lt;/a&gt;&amp;nbsp;&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/3383815247836641410/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2017/08/ich-guidelines-safety-guidelines.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/3383815247836641410'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/3383815247836641410'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2017/08/ich-guidelines-safety-guidelines.html' title='ICH Guidelines- Safety Guidelines'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-9216986083914026523</id><published>2017-08-14T09:17:00.000+05:30</published><updated>2020-05-15T20:29:21.294+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="ICH Guidelines"/><title type='text'>ICH Guidelines- Quality Guidelines</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;b&gt;ICH Quality Guidelines:&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Revised ICH Quality Guidelines are listed below:&lt;br /&gt;
&lt;br /&gt;
Q1A(R2) - Stability Testing of New Drug Substances and Products&lt;br /&gt;
&lt;br /&gt;
Q1B - Stability Testing: Photostability Testing of New Drug Substances and Products&lt;br /&gt;
&lt;br /&gt;
Q1C - Stability Testing for New Dosage Forms - Annex to the ICH Harmonised Tripartite Guideline on Stability Testing for New
Drugs and Products&lt;br /&gt;
&lt;br /&gt;
Q1D - Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products&lt;br /&gt;
&lt;br /&gt;
Q1E - Evaluation for Stability Data&lt;br /&gt;
&lt;br /&gt;
Q1F - Stability Data Package for Registration Applications in Climatic Zones III and IV&lt;br /&gt;
&lt;br /&gt;
Q2(R1) - Validation of Analytical Procedures: Text and Methodology&lt;br /&gt;
&lt;br /&gt;
Q3A(R2) - Impurities In New Drug Substances&lt;br /&gt;
&lt;br /&gt;
Q3B(R2) - Impurities in New Drug Products&lt;br /&gt;
&lt;br /&gt;
Q3C(R5) - Impurities: Guideline for Residual Solvents&lt;br /&gt;
&lt;br /&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;
Q4 - Pharmacopoeia&lt;br /&gt;
&lt;br /&gt;
Q4A - Pharmacopoeial Harmonization&lt;br /&gt;
&lt;br /&gt;
Q4B - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 4A(R1) - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Microbiological Examination of Non-Sterile
Products: Microbial Enumerations Tests&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 4B(R1) - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Microbiological Examination of Non-Sterile
Products: Test for Specified Micro-Organisms&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 4C(R1) - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Microbiological Examination of Non-Sterile
Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 1(R1) - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Residue on Ignition/Sulphated Ash&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 2(R1) - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Test for Extractable Volume of Parenteral
Preparations&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 3(R1) - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Test for Particulate Contamination: Sub-Visible
Particles&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 5(R1) - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Disintegration Test&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 6(R1) - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Uniformity of Dosage Units&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 7(R2) - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Dissolution Test&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 8(R1) - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Sterility Test&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 9(R1) - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Tablet Friability&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 10(R1) - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Polyacrylamide Gel Electrophoresis&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 11 - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Capillary Electrophoresis&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 12 - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Analytical Sieving&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 13 - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Bulk Density and Tapped Density of Powders&lt;br /&gt;
&lt;br /&gt;
Q4B Annex 14 - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Bacterial Endotoxins Test&lt;br /&gt;
&lt;br /&gt;
Q4B - Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions&lt;br /&gt;
Q5A(R1) - Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin&lt;br /&gt;
&lt;br /&gt;
Q5B - Quality of Biotechnological Products: Analysis of the Expression Construct in Cells used for Production of r-DNA Derived Protein Products&lt;br /&gt;
&lt;br /&gt;
Q5C - Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products&lt;br /&gt;
&lt;br /&gt;
Q5D - Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products&lt;br /&gt;
&lt;br /&gt;
Q5E - Comparability of Biotechnological/Biological Products Subject to Changes in their Manufacturing Process&lt;br /&gt;
&lt;br /&gt;
Q6A - Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances&lt;br /&gt;
&lt;br /&gt;
Q6B - Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products&lt;br /&gt;
&lt;br /&gt;
Q7 - Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients&lt;br /&gt;
&lt;br /&gt;
Q8(R2) - Pharmaceutical Development&lt;br /&gt;
&lt;br /&gt;
Q9 - Quality Risk Management&lt;br /&gt;
&lt;br /&gt;
Q10 - Pharmaceutical Quality System&lt;br /&gt;
&lt;br /&gt;
Q11 - Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities)&lt;br /&gt;
&lt;br /&gt;
Q12 - Lifecycle Management&lt;br /&gt;
&lt;br /&gt;
Ref:&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html&quot; target=&quot;_blank&quot;&gt;ICH Quality Guidelines&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/9216986083914026523/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2017/08/ich-guidelines-quality-guidelines.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/9216986083914026523'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/9216986083914026523'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2017/08/ich-guidelines-quality-guidelines.html' title='ICH Guidelines- Quality Guidelines'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2421819119883582274.post-8696580015925212679</id><published>2017-08-14T08:37:00.004+05:30</published><updated>2020-05-15T20:28:57.545+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Guidelines"/><category scheme="http://www.blogger.com/atom/ns#" term="ICH Guidelines"/><title type='text'>ICH Guidelines</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;b&gt;ICH Guidelines&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;background-color: white; color: #444444;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;The ICH topics are divided into four categories and ICH topic codes are assigned according to these categories:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;b&gt;1. Quality Guidelines:&amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;span style=&quot;background-color: white; color: #222222;&quot;&gt;Harmonisation achievements in the&amp;nbsp;&lt;/span&gt;&lt;b style=&quot;background-color: white; color: #222222;&quot;&gt;Quality&lt;/b&gt;&lt;span style=&quot;background-color: white; color: #222222;&quot;&gt;&amp;nbsp;area include pivotal milestones such as the conduct of stability studies, defining relevant thresholds for impurities testing and a more flexible approach to pharmaceutical&lt;/span&gt;&lt;b style=&quot;background-color: white; color: #222222;&quot;&gt;quality&lt;/b&gt;&lt;span style=&quot;background-color: white; color: #222222;&quot;&gt;&amp;nbsp;based on Good Manufacturing Practice (GMP) risk management.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;background-color: white; color: #222222;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;
&lt;a name=&#39;more&#39;&gt;&lt;/a&gt;&lt;span style=&quot;background-color: white; color: #222222;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;background-color: white; color: #222222;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;b&gt;2. Safety Guidelines:&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;background-color: white; color: #444444;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;ICH has produced a comprehensive set of safety Guidelines to uncover potential risks like carcinogenicity, genotoxicity and reprotoxicity. A recent breakthrough has been a non-clinical testing strategy for assessing the QT interval prolongation liability: the single most important cause of drug withdrawals in recent years.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;background-color: white; color: #444444;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;background-color: white; color: #444444;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;b&gt;3. Efficacy Guidelines:&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;background-color: white; color: #444444;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;The work carried out by ICH under the Efficacy heading is concerned with the design, conduct, safety and reporting of clinical trials. It also covers novel types of medicines derived from biotechnological processes and the use of pharmacogenetics/genomics techniques to produce better targeted medicines.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;background-color: white; color: #444444;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;background-color: white; color: #444444;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;b&gt;4. Multidisciplinary Guidelines:&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;background-color: white; color: #444444;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;Those are the cross-cutting topics which do not fit uniquely into one of the Quality, Safety and Efficacy categories. It includes the ICH medical terminology (MedDRA), the Common Technical Document (CTD) and the development of Electronic Standards for the Transfer of Regulatory Information (ESTRI).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;background-color: white; color: #444444;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif; font-size: large;&quot;&gt;&lt;span style=&quot;background-color: white; color: #444444;&quot;&gt;&lt;span style=&quot;font-family: &amp;quot;times&amp;quot; , &amp;quot;times new roman&amp;quot; , serif;&quot;&gt;&lt;b&gt;Ref:&lt;/b&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;color: #444444;&quot;&gt;http://www.ich.org/products/guidelines.html&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='https://guidelinesup2date.blogspot.com/feeds/8696580015925212679/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://guidelinesup2date.blogspot.com/2017/08/ich-guidelines.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/8696580015925212679'/><link rel='self' type='application/atom+xml' href='https://www.blogger.com/feeds/2421819119883582274/posts/default/8696580015925212679'/><link rel='alternate' type='text/html' href='https://guidelinesup2date.blogspot.com/2017/08/ich-guidelines.html' title='ICH Guidelines'/><author><name>Chinmay Patel</name><uri>http://www.blogger.com/profile/06638653687109547641</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='14' height='32' src='//blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3T4vk5Qb0fEd5mz3hudQcku2ldqK9ixa5FwT5rFiyagoCKA3z6knbHjmMJY_OvLks9lZj4IDlgKXynGEdqX8H-s6MBIBMkCamr0LKmnzWcMANHyGol4BL1C_5GA/s220/chinmay.jpg'/></author><thr:total>0</thr:total></entry></feed>